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Abstract  
Peptoids are peptidomimetic oligomers that predominantly harness similarities to peptides 
for biomimetic functionality. The incorporation of chiral, aromatic side chains in the peptoid 
sequence allows for the formation of distinct secondary structures and self-assembly into 
supramolecular assemblies, including microspheres. Peptoid microspheres can be coated onto 
substrates for potential use in biosensor technologies, tissue engineering platforms, and drug-
delivery systems. They have potential for use in biomedical applications due to their resistance to 
proteolytic degradation and low immunogenicity. This dissertation focuses on the physical 
characteristics and robustness of the peptoid microsphere coatings in various physiological 
conditions, along with their ability to serve as ELISA microarray and tissue engineering 
substrates. We have shown that the peptoid microspheres are suitable substrates for layer-by-
layer technologies to create biomimetic artificial extracellular matrices for tissue engineering. 
Overall, this study demonstrates that peptoid microsphere coatings are suitable materials for 
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Biomaterial research is an exciting field that has grown steadily over the last several 
decades. Biomaterials are made of either synthetic or natural components that are with biological 
systems [1]. They are typically designed to produce a precise reaction with the biological system 
for a specific application [2]. In 1987, the term, biocompatibility, was explained as the ability of 
a material to perform with an appropriate host response in a specific application [3, 4]. More 
specifically, the material does not induce undesirable responses and is not toxic, while also 
promoting the functionality of the device for its application [4].  
Progress in biomaterial design and engineering has enabled novel biomaterials to be 
prime candidates for applications in biosensing [5], tissue regeneration [6], and drug delivery 
systems [7]. Each specific application has guidelines for the biomaterial designation. For 
instance, drug delivery materials must allow for the controlled and targeted delivery of drugs 
without causing an unwanted immune response [8]. Therefore, it is important to create 
biomaterials with ideal properties and biocompatibility for the desired application.  
1.1 Types of Biomaterials  
Biomaterials can be divided into different material classes, including metals, ceramics, 
polymers, and composites [9]. Each type of material has unique surface chemistries and 
compositions that dictate their biological functionality. These properties can be tuned to have a 
desired effect on the biological response and outcome [10]. Metals are often used as medical 
implants in various parts of the body due to their inertness and excellent mechanical properties 
that prevent wear and fatigue of the material. Generally, the metal materials must be coated with 
a biopolymer to promote bio-functionality, such as blood compatibility and bioactivity necessary 
for successful implantation [11]. Ceramics, like metals, are commonly used as implants and for 
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the repair of damaged body parts. Alumina and zirconia are bio-inert ceramics, while calcium 
phosphates and glass-ceramics are considered bio-active ceramics. Both classes are used for the 
repair of diseased parts of the body by mimicking the natural calcified tissue [12]. Although 
useful as implants, metal and ceramic biomaterials are limited in other applications due to their 
difficult and expensive manufacturing process, and their lack of bio-functionality [11, 12].  
1.2 Biopolymers 
Biopolymers are chained molecules that are produced from living matter. The monomer 
units of biopolymers typically consist of amino acids for proteins/peptides, saccharides for 
sugars, or nucleotides for nucleic acids [13]. Peptides, specifically, are used in a variety of 
biomedical applications such as treatment for type 2 diabetes, prostate cancer, anemia, and many 
other diseases [14]. Peptides make excellent biotherapeutic and biomaterial candidates due to 
their good safety, efficacy, and high selectivity [15]. However, they are relatively chemically 
unstable due to the ease of proteolytic degradation in vivo causing their half-lives to be 
drastically reduced [16]. Proteins and peptides are also prone to aggregation, which can directly 
reduce their function and activity [17]. Synthetic peptides are of great interested because of their 
ease of synthesis and ability to mimic peptide sequences utilized in nature. They possess many of 
the advantages as natural peptides (e.g. biocompatibility, bioavailability, low toxicity), but are 
also prone to degradation when exposed to proteolytic enzymes [18, 19].  
The disadvantages of peptides have led researchers to pivot to new classes of non-natural 
polymers, called peptidomimetics, that are designed to mimic the function of natural peptides 
[16, 20]. These polymers often mimic the secondary and tertiary structure of peptides, but small 
structural differences result in more protease resistant molecules [21]. Examples of these 
molecules includes β-peptides and poly-N-substituted glycines (peptoids) [21, 22, 23]. These 
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compounds have shown excellent bioavailability and the ease of synthesis makes them ideal 
candidates for many biomedical applications.  
1.3 Applications for Biopolymers 
1.3.1 Drug Delivery Systems  
Although many biotherapeutic drugs have proven successful as treatment options for 
various diseases, there are still complications with delivery. Traditional routes, including oral, 
sub mucosal (nasal), parenteral (injection), and transdermal (through the skin) [24], are not 
feasible due to enzymatic degradation and low absorption efficiency [25]. The oral delivery of 
biotherapeutic proteins faces issues with poor absorbance within the gastrointestinal system and 
chemical degradation due to harsh enzymes within the digestive system, resulting in the loss of 
activity and function [26]. These pH-sensitive drugs are prone to degradation within the colon’s 
harsh environment [27].  Subcutaneous injections and transdermal administration routes are 
challenging due to immunogenic potential and unwanted immune responses [28]. It has been 
reported that subcutaneous degradation occurs with protein-based drugs due to the lymphatic 
transfer of these proteins when delivered parenterally [29]. Nasal drug delivery is of interest due 
to the high vascularity and permeability within the nasal mucosa [30, 31]. As seen with other 
delivery methods, the body’s immune defense mechanism bodes an even bigger issue. If the 
biotherapeutic causes any irritation in the nasal mucosa, then the mucocillary clearance 
mechanism will cause the drug to be rapidly diluted, increasing the clearance by forming nasal 
mucus that will be eliminated from the nose [32]. For this reason, drug delivery systems are 
growing in interest to combat the immunogenicity issues of protein therapeutics.  
Drug delivery systems help facilitate the successful delivery of a drug candidate to 
specific body sites. Currently, most drug delivery systems are within the colloidal size range (1-
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1000nm), and act to release the drug at a controlled rate for a prolonged period of time [33]. The 
drug is typically kept within a solid inner matrix that is layered by a permeable outer polymeric 
membrane through which the drug diffuses [34]. 
 Focus has been on biopolymer drug delivery systems created from both synthetic and 
natural polymers, such as polylactic-co-glycolic acid (PLGA) nanoparticles and lipid-based 
carriers, respectively. PLGA nanoparticles are attractive for drug delivery due to their 
biodegradability and biocompatibility, FDA approval in parenteral administration systems, well-
described production and characterization methods, protections from drug degradation, sustained 
release capabilities, possibility to modify surface properties, and target specificity for desired 
organs or cells [35]. Despite these desirable properties, PLGA-nanoparticles have their 
limitations when dealing with certain biotherapeutics such as peptides and proteins. The 
synthesis process of these nanoparticles involves factors and processes that may cause the 
protein to become aggregated and denatured [36]. Another issue associated with the use of 
nanoparticles is the complexity of cellular uptake and the unknown stability and cytotoxicity of 
the nanoparticles following metabolism [37, 38]. Liposomes and lipid-based carriers have 
already had a major impact on targeted therapeutic protein delivery. Liposomes are defined as 
phospholipid vesicles consisting of multiple lipid bilayers enclosing discrete aqueous spaces 
[39]. Liposomes and lipid-based carriers are advantageous as drug delivery systems due to their 
biocompatibility, ability to self-assemble, extended drug circulation time, and their ability to 
carry multiple drugs at once [40]. However, as with other drug delivery systems, lipid-carriers 
are still susceptible to enzyme degradation, primarily in the spleen and liver [41].  
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Therefore, it is necessary to create a robust drug delivery system that better protects the 
therapeutic drug from enzymatic degradation, while also promoting the selective release at the 
target location.  
1.3.2 Disease Detection  
The overall knowledge and treatment options for various types of cancers has drastically 
increased over the past several decades. Although there is much optimism within the cancer 
biology field, as seen by increased cancer survival rates, there is still plenty of work to be done 
towards diagnostic tools. Diagnosis of a disease typically follows the first sign of symptoms, 
which in many cancers, is considerably too late. There is a direct correlation between mortality 
rates and disease progression [42]. If caught early, many forms of cancer and other diseases can 
be treated effectively. However, early stages of cancer are often asymptomatic, and diagnosis 
relies on the observation of tumor growth. The National Cancer Institute’s SEER Program 
studied this correlation and showed that the 5 year survival rate in skin cancer (92%) and breast 
cancer (89%) were must higher than those for internal organs, such as lung cancer (21%) and 
pancreatic cancer (10%) [43]. The most common diagnostic techniques include taking a biopsy 
of the tumor site or performing imaging techniques (e.g. CT scan, MRI, ultrasound, nuclear scan, 
or PET scan) [44]. Unfortunately, these techniques do not provide a platform for early detection 
due to the tumor already being present.  
The early detection of disease reduces the economic burden by decreasing the amount 
and extensiveness of treatments, while also decreasing the mortality associated with the disease 
[45]. Ideal diagnostic technologies would be able to detect molecular changes present in 
asymptomatic populations during the onset of disease with high specificity. Researchers have 
focused their efforts on developing biomarker-based technologies due to their sensitivity and 
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ability to provide information on the state of a biological process [46]. Cancer biomarkers can 
display the genotoxicity, hyperproliferation, hyperplasia, inflammation, mutations, altered 
patterns of gene and protein expression, promoter methylation, and enzymatic changes that occur 
in response to disease [46, 47]. Protein-based biomarkers provide a natural platform that relies on 
the identification of altered protein expression levels in disease states [48, 49]. To detect and 
quantify the protein levels, researchers have looked at antibody-based arrays because of their 
high target specificity [50]. Unfortunately, the approval rate for these biomarkers is hampered by 
the molecular heterogeneity for various populations of tumor tissues.  
Enzyme-linked immunosorbent assay (ELISA) microarray technology was developed in 
the early 2000’s [51, 52] for the purpose of analyzing numerous biomarkers in parallel with 
higher sensitivity than traditional immunoassays [53, 54]. It is considered a low-cost and 
efficient screening technology that uses small volumes of clinical samples and expensive 
antibodies to test multiple proteins at the same time, also known as multiplex [55]. The design of 
ELISA microarray involves the immobilization of small amounts of antibodies onto a solid 
support in an ordered pattern, a microarray [52]. The antibodies bind protein analytes onto the 
surface, in which the microarrays are then incubated with the clinical sample and tagged for 
fluorescent detection.  
The challenge to ELISA microarray and other protein/antibody microarrays is producing 
a slide surface that promotes strong antibody attachment, without disrupting the high binding 
capacities, signal-to-noise ratios, and reproducibility. These surface structures also have to be 
robust enough to retain high specificity and sensitivity levels through rigorous processing 
conditions and prolonged storage periods [56, 57]. These microarray surfaces are typically 
defined as either two-dimensional or three-dimensional surfaces. Glass slides are frequently used 
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for two-dimensional solid support platforms, where they must be functionalized with various 
chemicals (e.g. aldehyde, aminosilane, epoxysilane, mercaptosilane, polystyrene, and poly-L-
lysine) to promote antibody attachment [58]. The covalent attachment of antibodies to two-
dimensional surfaces results in strong attachment, but the close contact with the surface can 
affect the protein structure and function [59].  
Three-dimensional surfaces immobilize proteins through physical adsorption from the 
hydrophobic interactions within their structures. This results in the proteins maintaining their 
native structure forming a more optimal surface with increased binding capacities and signal 
intensities [60]. In theory, increasing the surface area by using three-dimensional substrates for 
antibody attachment should enhance the microarray results by providing more sites of attachment 
to increase signal intensity and the dynamic range. Polymer-based surfaces that increase surface 
area such as polyacrylamide [47, 61], agarose [62], and nitrocellulose [63] suffer from low 
signal-to-noise ratios due to absorption of protein in the porous coating [64]. 
1.3.3 Tissue Engineering 
According to an American Heart Association study in 2015, there are nearly 800,000 
persons in the United States that suffer from stroke and over 140,000 die each year. Strokes are 
the fifth leading cause of death and considered the leading cause for serious long-term disability 
[65]. A stroke occurs when blood is restricted from the brain by either a blood clot (ischemic) or 
ruptured blood vessel (hemorrhagic) causing irreversible damage through the formation of 
cavities, or areas of dead brain tissue [66]. Current treatment options are limited to surgically 
repairing the ruptured blood vessel or using tissue plasminogen activator (tPA) to break up the 
clot. However, these treatments hold much risk due to the invasiveness and potential for 
infection that surgery poses, as well as the fact that tPA is only successful if used within the first 
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few hours from the onset of symptoms [67]. Often the patients are left with lifelong impairments 
in their motor function and lose the ability to complete routine tasks such as reading, writing, and 
talking.  
In order to combat central nervous system (CNS) damage it’s important to gain a better 
understanding of the self-renewal ability and neurogenesis of neuronal stem cells. Past evidence 
has shown that human neurons naturally undergo neurogenesis within two areas of the brain: the 
hippocampal dentate gyrus and the anterior subventricular zone [68, 69]. Self-renewal of these 
cells is often limited to low amounts of healthy neurons that decrease with age and severity of 
brain injury [70]. The mechanism of neurogenesis is of interest within the regenerative biology 
and tissue engineering fields where healthy neuronal cells, molecules, and supporting structures 
are implanted into diseased tissue to promote neuron regeneration [71, 72]. The ability of 
embryonic stem cells (ESCs) and human mesenchymal stem cells (hMSCs) to grow and 
differentiate into multiple cells types, especially neuronal cells, make them an interesting 
candidate for stroke, traumatic brain injury, and PNS injury treatment [73, 74]. 
Human embryonic stem cells are multipotent cells derived from the undifferentiated germ 
layers found in early developing embryos, called blastocysts [75]. Mesenchymal stem cells are 
easily isolated from adult bone marrow tissue and, like hESCs, are multipotent and possess self-
renewable properties [76]. Both cell types can be directed to differentiate into specific adult cell 
lineages depending on the cellular microenvironment for various cell therapy applications. To be 
a viable tissue regeneration option there needs to be a better understanding in the differentiation 
pathways and what role the environment plays in dictating the stem cell fate.  
The extracellular matrix (ECM) is a three-dimensional network composed of proteins and 
macromolecules that physically support surrounding cells [77]. The ECM’s biochemical 
 9 
composition and surface play a major role in stem cells’ ability to grow and differentiate into 
adult cell types [78]. The topography and spatial arrangement of features on artificial ECM 
surfaces has shown to guide stem cell attachment and differentiation into specific adult cell types 
[79]. Current artificial ECM materials are made from either natural or synthetic components. 
Natural components include both proteins (laminin, collagen, fibronectin, etc) and carbohydrates, 
primarily glycosaminoglycans (heparin, chondroitin sulfate, and hyaluronic acid) and 
polysaccharides (chitosan and cellulose) [80]. Although suitable, these materials are often 
difficult to isolate and purify making them expensive to culture cells in large quantities. Along 
with the cost, the natural materials can be easily degraded when exposed to cellular conditions 
for extended periods of time and are limited to two-dimensional networks [81].  
Synthetic components typically consist of nanomaterials, hydrogels, membranes, and non-
natural polymers. The advantages to using synthetic ECM mimics is that they are more 
consistent and customizable than naturally derived materials. There is less batch-to-batch 
variability and the chemistry and mechanical properties can be tuned to suit an individual 
application [82]. For years, polyglycolic acid (PGA), poly(L-Lactic acid) (PLLA), poly)lactic-
co-glycolic acid) (PLGA), poly(anhydrides), and poly(orthoesters) have been used to fabricate 
synthetic ECMs [83]. These polymers possess excellent biocompatibility, the degradation rate 
can be tailored, and they can easily be molded and cast into desired shapes and sizes [84]. Most 
synthetic ECM materials do not directly mimic the in vivo cell environment and lack critical 
biomolecular signaling dynamics [85]. There is a need for a material that directly mimics the 
three-dimensional substrates found in neuronal networks to gain a better understanding of the 
effect of topographical cues on neuronal stem cell fate.  
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1.4 Peptoids (Poly-N-Substituted Glycines) 
Naturally occurring peptides possess excellent biological properties that theoretically make 
them ideal candidates for biomedical applications. However, due to their susceptibility to in vivo 
proteolytic degradation they are actually limited in their functionality. Research efforts have 
focused on creating peptidomimetics, non-natural polymers that are designed to directly mimic 
peptides. Peptidomimetics are structurally and functionally similar to peptides but have improved 
stability against proteolysis and increased bioavailability [86]. Peptides often utilize their ability 
to assemble into complex three-dimensional secondary and tertiary structures. In order to mimic 
these advanced structures of peptides, specific peptidomimetics, called foldamers, also display 
well-defined secondary and tertiary structures [21].  
Peptoids, or N-substituted glycines, are synthetic peptidomimetic oligomers that structurally 
resemble α-peptides but have side chains attached to the amide groups on the backbone instead 
of the α-carbon as in peptides (Figure 1.1) [23]. This structural modification generates an achiral 
backbone that eliminates the potential for hydrogen bonding, resulting in a protease-resistant 
polymer that exhibits good cell computability and protein binding characteristics resembling that 
of more “drug-like” molecules [87]. The small size and protease-resistance also makes peptoids 
biocompatible as they are unlikely to illicit an immune response. 
 11 
 
1.4.1 Peptoid Synthesis 
The ease and efficiency of peptoid synthesis makes them an attractive peptidomimetic 
polymer. Peptoids can be produced via a sequence-specific, solid-phase synthesis method 
comparable to that of peptides [89]. Unlike peptide synthesis, where submonomers must be 
protected prior to addition, peptoid synthesis allows for the precise addition of unprotected 
submonomers greatly simplifying the process. The submonomer method is a highly efficient, low 
cost synthesis technique that allows for the addition of a wide variety of side chains as primary 
amines [89].  




Using a solid-phase support (ex: rink amide resin), submonomers are added from carboxylic 
to amine termini via a submonomer “cycle” made up of two-steps: (1) acylation and (2) 
amination (nucleophilic substitution) (Figure 1.2) [89]. The first reaction of the submonomer 
cycle, acylation, adds an activated carboxylic acid derivative onto a receptive amine generating a 
tertiary amide bond. In general, bromoacetic acid (BAA) and diisopropylcarbodiimide (DIC) are 
used for acylation. The BAA is activated by DIC separately, and then added to the solid-phase 
support [89]. The second step in the cycle, amination, involves the nucleophilic displacement of 
the halide (typically bromine) by a primary or N-terminal secondary amine (side chain). As the 
halide group is removed from the haloacetamide, the primary nitrogen submonomer attacks the 
alpha-carbon forming an ammonium salt. The halide ion then removes hydrogen from the 
ammonium salt producing hydrogen bromide. The amination step creates the molecular diversity 
that is present in peptoids due to the thousands of commercially available amine side-chains. 
Once synthesized, the peptoid molecule is cleaved from the resin and purified using preparative 
high-performance liquid chromatography.  
 




1.4.2 Peptoid Microspheres  
The backbone modification in peptoids eliminates the potential for hydrogen bonding, which 
is critical for secondary structure formation in peptides. However, including chiral side chains 
can induce secondary structures in peptoids such as turns, loops, and helices that allow for the 
formation of supramolecular assemblies [90, 21]. Peptoid helices are extremely robust as they 
are stabilized by steric hindrance and electrostatic repulsions between the side chains [90]. 
Peptoid homooligomers of (S)-methylbenzylamine as short as five monomers have shown 
polyproline type-I-like helices confirmed by circular dichroism (CD). The presence of minima at 
207 nm and 2011 nm and a maximum at 190 nm resemble the spectrum for a peptide α-helix 
[92]. 
The Servoss lab has demonstrated that helical peptoids with partial water solubility self-
assemble into microspheres in solution and can be cast onto a solid surface to form coatings. The 
peptoid of interest, P3, contains chiral, aromatic side chains that are positioned on two faces of 
the helix (Figure 3) to induce secondary structure and ultimately form microspheres 
(supramolecular structure) (Figure 4). The third face of the helix contains positively charged 
lysine-like side chains to enhance binding onto various substrates and incorporation of other 
adducts. The peptoid sequence and the effect that side chain placement (charge and bulk) along 
with the partial water solubility and helical content have been studied in detail [92, 93, 94]. 
Dissolving the peptoid in a 4:1 alcohol to water solution enables the formation of microspheres 
that can optimally be coated onto glass substrates. Further work has investigated the factors that 
affect the reproducible nature of microsphere coating formation including solvent effects, 
administration techniques, and drying conditions. These studies have shown that a 4:1 solution of 
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ethanol: water, drop-coating, and drying at 55% humidity produces optimal coatings that have 
excellent microsphere coverage. 
 
 
The peptoid microsphere coatings have excellent potential as drug delivery agents, 
biosensors, and artificial extracellular matrices. They are advantageous for the applications due 
to their topographical features, biocompatibility, and customizability. The spatial arrangement 
and contact angle of the microsphere coatings can be tuned for desired topographical properties. 
The positive surface charge of the microspheres can also be utilized in adding natural ECM 
components, such as laminin, collagen, heparin, and fibronectin, through polyelectrolyte 
multilayers.  


































1.5 Polyelectrolyte Multilayers  
Polyelectrolyte coatings are rapidly gaining interest as biomaterials for various medical and 
pharmacology applications due to their ease and versatility [95]. Layer by layer (LbL) formation 
of polyelectrolyte multilayers (PEMs) is an intriguing method for surface modifications and 
nanoscale material synthesis. LbL utilizes the ionic attraction between opposite charges in 
alternating the adsorption of anionic and cationic polyelectrolytes [96]. The ability of PEMs to 
tune the chemical, physical, and topographical properties simply by altering the pH, ionic 
strength, number of layers, and layer thickness makes them ideal candidates for aECM substrates 
[97]. PEMs can be assembled by both naturally occurring and synthetic polymers where the 
library of potential polymers is endless. For example, PEMs constructed from naturally occurring 
polymers, heparin and collagen doped with IFN-γ, were able to promote enhanced cellular 
behaviors in human mesenchymal stem cells [98]. The tunability of PEM films make them 
interesting candidates as aECM substrates for neurogenesis in tissue engineering applications.  
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2. Research Rationale  
This dissertation is focused on developing and characterizing peptoid microspheres (Chapter 
3) as suitable substrates for biosensing (Chapter 4), LbL fabrication (Chapter 5), and tissue 
engineering applications (Chapter 6). It supports work done by Jesse Roberts and Dr. Shannon 
Servoss to assemble a novel, three-dimensional peptoid substrate for biosensing and tissue 
engineering applications. The peptoid microspheres provide potential to be a more biocompatible 
and customizable substrate than commercially available polymer-based substrates. The peptoid 
microspheres possess the ability to attach other naturally occurring biopolymers (laminin, 
collagen, heparin, etc.) through polymeric multilayer fabrication methods to combine the 
topography and surface chemistry that the stem cells favor.  
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3. Peptoid Microsphere Coatings: The Effects of Helicity, pH, and Ionic Strength 
German R. Perez Bakovic, Jesse L. Roberts, Bryce Colford, Myles Joyce, and Shannon L. 
Servoss  
Ralph E. Martin Department of Chemical Engineering, University of Arkansas Fayetteville 
Abstract  
Peptoids are peptidomimetic oligomers that predominantly harness similarities to peptides 
for biomimetic functionality. They have potential for use in biomedical applications and 
biosensors due to resistance to proteolytic degradation and low immunogenicity. The 
incorporation of chiral, aromatic side chains in the peptoid sequence allows for the formation of 
distinct secondary structures and self-assembly into supramolecular assemblies, including 
microspheres. Peptoid microspheres can be coated onto substrates for potential use in biosensor 
technologies, tissue engineering platforms, and drug-delivery systems. In order to be useful for 
these applications, the peptoid coatings must be robust under physiological conditions. In this 
study we report the effects of various conditions on the peptoid microsphere coatings, including 
(i) helicity, (ii) temperature (iii) pH, and (iv) ionic strength. These studies show that microsphere 
size decreases with increasing peptoid helicity and the positively charged side chains are 
positioned on the outside of the microspheres. The peptoid microsphere coatings are robust under 
physiological conditions but degrade in acidic conditions (pH < 7) and at low ionic strengths (< 





3.1 Introduction  
Natural polymers, such as proteins and peptides, have inspired the development of 
synthetic materials that mimic the fundamental molecular features, and are therefore also able to 
mimic the function. [1] While proteins and peptides have a myriad of unique functional 
properties, as biomaterials they are limited due to proteolytic degradation and as a result are 
restricted in their potential for use in biomedical and therapeutic applications. [2] Efforts to 
overcome these limitations have led to the design and development of innovative peptidomimetic 
oligomers. [3, 4, 5, 6, 7, 8] These synthetic oligomer analogs largely exploit structural similarities to 
allow for bioactive functionalities. Some bioactive roles are determined by the unique ability of 
proteins and peptides to self-assemble into complex, sequence-specific secondary and 
supramolecular structures. [9] Specific peptidomimetic oligomers, commonly referred to as 
foldamers [10], display well-defined secondary structures, and are therefore of great interest for 
use in biomaterials. 
One class of foldamers, peptoids or poly-N-substituted glycines, closely resemble 
peptides, with the side chains attached to the backbone amide nitrogen rather than the backbone 
α-carbon as in peptides. This seemingly minor modification to the backbone has important 
implications to peptoid structure and function, including reduced proteolytic degradation that 
makes them a promising alternative to peptides for therapeutic applications where proteolysis is 
of major concern. The backbone modification also prevents hydrogen bonding within the 
backbone, which is critical for the formation of secondary structure in peptides. However, 
including specific side chains can induce the formation of peptoid secondary structures such as 
turns [11, 12], loops [13], and helices [14, 15, 16, 17, 18] that allow for the formation of supramolecular 
assemblies. [19, 20, 21, 22, 23, 24] For peptoid homooligomers of (S)-methylbenzylamine, stable helices 
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are formed with as few as five monomer units and full helicity is reached at 13 monomer units. [9] 
The circular dichroism (CD) spectra strongly resembles that for protein α-helices [9] and NMR 
confirms a helical structure similar to protein polyproline type-I helices, with a periodicity of 
three residues per turn and a helical pitch of ~6 Å. [16] Like peptides, peptoids are constructed via 
solid-phase synthesis, but following a submonomer method that provides a robust and highly 
efficient synthesis platform with precise sequence control. [25] Side chains are introduced by the 
incorporation of commercially available primary amines, enabling access to more than 300 side 
chain chemistries. [1]  
Previous work has focused on the effects of peptoid water solubility, helical content, 
charge placement, and side chain bulk on self-assembly into microspheres. [24] Both peptoid 
helicity and partial water solubility were found to be crucial for microsphere formation. The 
microspheres (0.3 – 3.6 µm) are orders of magnitude larger than the length of a single peptoid 
helix (~24 Angstrom), suggesting that larger peptoid groupings are formed by stacking of the 
chiral aromatic groups. [24] Aromatic stacking has been observed in similar types of 
supramolecular assemblies for both peptides and peptoids. [26, 22, 27, 28, 29] Further, peptoid 
sequences with alternating positive and negative charges on one face of the helix produce smaller 
microspheres (~0.3 μm) as compared to those with alternating positive and neutral charges on 
one face of the helix (~1.5 μm).  It is believed that the opposite charges interact to form tighter 
helices, resulting in smaller microspheres. [24] Further work in the Servoss lab investigated the 
factors that affect the reproducible formation of microsphere coatings including solvent effects, 
administration technique, and drying conditions. [30] These studies showed that reproducible 
coatings were formed by solubilizing the peptoid in an aqueous solution of protic solvent, 
completely covering the surface with solution, and allowing it to dry at room temperature with 
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60% humidity.  
Potential applications for peptoid microspheres include biosensors, artificial extracellular 
matrices, and drug delivery systems. The customizability of the microsphere chemistry allows 
for the fine-tuning based on application or environment. The work reported here shows the effect 
of peptoid length (and in turn helicity) on microsphere size, as well as the effects of temperature, 
pH, and ionic strength on the robustness of peptoid microsphere coatings. The surface charge and 
phase transition temperatures of the different peptoid lengths were measured using zeta potential 
and differential scanning calorimetry (DSC), respectively. Scanning electron microscopy (SEM) 
and ImageJ processing show that as peptoid chain length, or helicity, is increased microsphere 
size decreases and the size distribution increases. Zeta potential proved that there is a positive 
charge located on the outer surface of the peptoid microspheres, and DSC showed that the 
melting temperatures ranged from 78-83°C for the various peptoid lengths. Furthermore, SEM 
confirmed that the microsphere coatings are extremely robust under physiological conditions, 
however they degraded in low ionic strength and low pH solutions.   
3.2   Materials and Method 
3.2.1 Materials 
 (S)-methylbenzylamine and 4-methoxybenzylamine were purchased from Acros 
Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl)carbamate was purchased from CNH 
Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from NovaBiochem 
(Gibbstown, NJ). Piperidine was purchased from Sigma-Aldrich (St. Louis, MO). Ultra clean 
glass microarray slides, and disuccinimidyl suberate (DSS) were purchased from Thermo 
Scientific (Pittsburgh, PA). All other reagents were purchased from VWR (Radnor, PA). All 
chemicals were used without further modifications unless otherwise specified.  
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3.2.2 Peptoid Synthesis, Purification, and Characterization 
Peptoids were synthesized following a submonomer, solid-phase method on rink amide 
resin, as previously described. [25, 31] Synthesis follows a carboxy to amino direction and the 
submonomer method includes two steps: acylation to extend the backbone and nucleophilic 
substitution to incorporate the side chain. [32] Briefly, the resin was swelled with 
dimethylformamide (DMF), and the Fmoc protecting group was removed using a 20% solution 
of piperidine in DMF. The resin-bound secondary amine was acylated with 0.4 M bromoacetic 
acid in DMF in the presence of N,N’-diisopropyl carbodiimide, mixing for 1 minute. Amine 
submonomers were incorporated via an SN2 nucleophilic substitution reaction with 0.5 M 
primary amine in DMF, mixing for 2 minutes. The two-step acylation and nucleophilic 
substitution cycle was repeated until the desired sequence was obtained. The peptoid was cleaved 
from the resin using a mixture of 95% trifluoroacetic acid (TFA), 2.5% water, and 2.5% 
triisopropylsilane.  
Peptoids were purified using a Waters Delta 600 preparative high-performance liquid 
chromatography (HPLC) instrument (Milford, MA) with a Duragel G C18 150 × 20 mm column 
(Peeke Scientific, Novato, CA) and a linear gradient of 35-95% solvent B (acetonitrile, 5% 
water, 0.1% TFA) in A (water, 5% acetonitrile, 0.1% TFA), over 60 minutes.  Peptoids were 
confirmed to be >98% pure via analytical HPLC (Waters Alliance) with a Duragel G C18 150 × 
2.1 mm column (Peeke Scientific) using a linear gradient of 35-95% solvent D (acetonitrile, 
0.1% TFA) in C (water, 0.1% TFA), over 30 minutes. Presence of the desired sequence was 
confirmed via matrix assisted laser desorption/ionization time of flight (MALDI-TOF) mass 
spectrometry (Bruker, Billerica, MA). Purified peptoid fractions were lyophilized and stored as a 
powder at -20 °C. 
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3.2.3  Circular Dichroism 
Peptoid secondary structure was confirmed via circular dichroism (CD) spectroscopy 
using a Jasco J-715 instrument (Easton, MD). The peptoids were dissolved in methanol at a 
concentration of 60 µM. Data was collected at room temperature with a scanning speed of 20 
nm/min in a cuvette with a path length of 0.2 mm. Each spectrum was the average of twenty 
accumulations. 
3.2.4 Peptoid Microsphere Coatings 
Peptoid microspheres were prepared by dissolving the peptoid in a 4:1 ethanol/water 
(v/v) solution at a concentration of 5 mg/mL. The peptoid solution was applied to glass 
substrates using a pipette and allowed to dry at room temperature and 60% relative humidity for 
one hour. Coating morphology was imaged using a Phillips XL-30 environmental scanning 
electron microscope (SEM; FEI, Hillsboro, OR). 
3.2.5 Microsphere Size Analysis 
Particle size analysis was performed using ImageJ software (National Institute of Health, 
MD). Noise reduction was completed with a fast Fourier transform (FFT) band-pass filter 
normalization, eliminating low- and high-spatial frequencies and transforming the original SEM 
images to a two-dimensional representation of the frequency. The images were converted to 8-bit 
grayscale and binarized adjusting the white and black threshold to optimize particle contrast with 
the background. Greater than 200 particles were manually evaluated for each experimental 
condition and plotted using Origin2018. 
3.2.6 Surface Charge Measurements 
The surface charge of the peptoid microspheres was measured in terms of zeta potential 
using a Beckman Coulter Delsa NanoHC instrument (Brea, CA). A flat cell was employed for 
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determination of the zeta potential of the peptoid microspheres. The peptoid microsphere 
coatings were submerged in the feed solution that was set at a neutral pH of 7.0 and the 
measurements were taken.  
3.2.7 Differential Scanning Calorimetry 
The melting temperature and phase transition properties of the peptoid microspheres were 
measured using a TA Instruments Differential Scanning Calorimeter Model 25 (New Castle, 
DE). The peptoid microspheres were formed by dissolving peptoid in a 4:1 ethanol/water (v/v) 
solution at a concentration of 3 mg/mL. The peptoid microspheres were deposited onto a TA 
Instruments Tzero aluminum pan at a constant volume of 60 µL. The pan was set in a holding 
vessel where a lid was hermetically sealed using a specialized Tzero Press. Individual sample 
masses were taken and documented in the DSC control software, TRIOS v4.4, where after 
temperature equilibration at 0 °C, an isothermal period of ten minutes was completed. The 
ramping period of 20 °C per minute up to a maximum temperature of 200-240 °C was used to 
determine the phase transition and melting temperature of the peptoid microspheres. Upon 
conclusion, the plot of normalized heat flow (W/g) versus temperature (°C) was analyzed and the 
peak integration function within TRIOS resulted in the normalized enthalpy (J/g) and peak 
temperature (°C) for phase change.  
3.2.8 Coating Robustness Under Biological Assay Conditions 
The robustness of the peptoid microsphere coatings was assessed by incubation in 
solutions common to bioanalytical assays that have various values of pH and ionic strengths. 
Specifically, the coatings were incubated in 10 mg/mL casein in phosphate-buffered saline (PBS; 
pH 7.3, ionic strength 150 mM) for one hour, 0.05% Tween in PBS (PBS-T; pH 7.3, ionic 
strength 150 mM) for 12 hours, 0.003% hydrogen peroxide in 0.1M sodium borate (pH 8.2, ionic 
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strength 600 mM) for 10 minutes, and nanopure water (pH ~7, ionic strength ~0 mM) for up to 
30 minutes.  
3.2.9 Effect of Temperature, pH, and Ionic Strength on Coating 
The ability of the peptoid microsphere coatings to withstand temperature, pH, and ionic 
strength was assessed through incubation in various solutions.  The effect of temperature was 
evaluated by incubating the peptoid microsphere coatings in PBS and water at 37 °C. The 
temperature of both PBS and nanopure water was preheated and kept constant at 37 °C using a 
covered incubation chamber and hot plate. The pH and ionic strength robustness studies were 
assessed by incubating the peptoid microsphere coatings in solutions ranging from pH 3-11 and 
ionic strength of 0-500 mM at room temperature (25°C). The solution pH was adjusted by 
adding a stock hydrochloric acid or sodium hydroxide solution drop-wise until the desired pH 
was attained. The coatings were incubated in solutions of different pH values (pH = 3, 4, 5, 6, 7, 
8, 9, 10, 11) for one hour. The ionic strength of water and PBS was adjusted using a stock 
potassium chloride solution until the desired ionic strengths were obtained. The coatings were 
incubated in solutions of different ionic strength values (ionic strength = 0, 50, 100, 150, 250, 
500 mM) for one hour. The robustness of the peptoid microsphere coatings was assessed via 
SEM by analyzing microsphere morphology and surface coverage. 
3.3   Results  
3.3.1 Peptoid Sequence and Characterization 
The peptoid sequences used in this study (Figure 3.1A) are based on that of a helical and 
partially water soluble 12mer that was previously reported to form microspheres. [24] Helical 
secondary structure is induced by including two-thirds chiral, aromatic side chains (Nspe) such 
that two faces of the helix contain Nspe side chains (Figure 3.1B). This configuration allows for 
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interactions between the benzene rings on different peptoid molecules. The third face of the 
peptoid helix contains alternating side chains with amine and methoxybenzyl groups to increase 
water solubility, as well as facilitate attachment to glass substrates. In this study, the length of the 
peptoid was varied by repeating the same six monomer unit for final lengths of 6, 12, 18, and 24 
monomers (Figure 3.1A).  
Peptoid helicity was assessed by CD spectroscopy (Figure 3.2). The 12mer, 18mer, and 
24mer peptoids exhibit a maximum near 193 nm and two minima near 208 and 222 nm, 
indicative of polyproline type-I-like peptoid helices. [32] The 6mer also displayed a maximum 
near 193 nm and a minima near 222 nm; however, a second minima at 200 nm indicates both 
random coil and polyproline type-I-like peptoid helix secondary structures. [33] The relative 
helicity increases with peptoid length, as evidenced by the increasing intensity of the minimum 
peak at 222 nm. [34] This corresponds to previous studies, which have shown that peptoid helicity 
increases with peptoid length. [9] This is further corroborated by molecular simulations. [35] These 
studies, which were validated by NMR experiments, show that peptoid helix formation is a 
function of temperature and chain length; ultimately, proving that as chain length increases 
Figure 3.1 (A) Linear peptoid sequence. Four peptoids were studied: 6mer (n=1, MW=968), 
12mer (n=2, MW=1919), 18mer (n=3, MW=2870), and 24mer (n=4, MW=3821). (B) 
Representation of the 12mer peptoid helix.  
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helicity increases and peptoid helix formation is thermodynamically favorable. [35, 36] 
3.3.2 Effect of Helicity on Microsphere Size and Distribution 
It is desirable to tune the size of microspheres for different applications. Based on our 
previous results, [30] we hypothesized that peptoids with tighter helicity would form smaller 
microspheres. The formation of microspheres by peptoids with different helicities (6mer, 12mer, 
18mer, and 24mer) was tested. The peptoids were solubilized in 4:1 ethanol:water and dried on 
glass substrates to form the microsphere coatings. Microsphere size was visually assessed by 
SEM and measured using ImageJ software. The 6mer peptoid did not form microspheres (Figure 
S3.1 in Supplemental Information), likely due to decreased helicity, increased water solubility, 
and the limited number of aromatic side chains to induce stacking. The 12mer, 18mer, and 24mer 
peptoids all formed microspheres of different sizes (Figures 3.3A, 3.3B, and 3.3C, respectively). 
As expected, microsphere diameter decreased with increasing helicity, with average diameters of 
2.26 μm, 1.91 μm, and 1.24 μm for the 12mer, 18mer, and 24mer peptoids, respectively.  
Figure 3.2 Circular dichroism spectra for 6mer, 12mer, 
18mer, and 24mer peptoid in methanol at 60 µM. 
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The decrease in size is likely due to the increased interactions between the peptoids that 
have higher helical content, and therefore closer packing in the microspheres. Conversely, 
peptoids with more loose helical structure are not able to pack as tightly and form larger 
microspheres. In addition, there is a direct relationship between peptoid length and microsphere 
size distribution, with the most uniform size distribution observed for the 12mer peptoid (Figures 
3.3A and 3.3D) and the most disperse sizes observed for the 24mer peptoid (Figures 3.3C and 
3.3F).  
Like the peptoid microspheres, peptide foldamers use their molecular interactions to form 
distinct secondary structures that can be tailored into self-assembling supramolecular structures 
(spherical micelles [37], worm-like micelles [38], lamellar sheets [39], vesicles [40], nanotubes [41] ,and 
fibrils [42]). The size of spherical micelles formed from thermally responsive elastin-like peptides 
can be tuned through the secondary structure by altering the total chain length and the 
hydrophilic-hydrophobic chain ratio in the peptide. [37] Peptide nanotubes can be formed by 
incorporated cyclic peptides with D- and L- amino acids that self-assemble through antiparallel 
hydrogen bonding and stereochemical interactions of the peptide backbone. [43] By strategically 
assembling the peptide entities at specific ratios and altering the number of amino acids, the 
overall length and size of the peptide nanotube can be controlled for desirable end-product 
formation. [44] These supramolecular structures prove that the overall size is a function of 
secondary structure and intermolecular interactions, like the helicity of the peptoid microspheres.  
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3.3.3 Surface Charge of Peptoid Microspheres  
The surface charge, or zeta potential, of the different length peptoids was obtained using 
electrophoretic light scattering (ELS). The zeta potential gives the potential difference between 
the solid-liquid interface of the charged particle and the liquid media. It is hypothesized that the 
positively charged side chains are located on the outside of the microspheres due to the stacking 
of the aromatic groups, as well as the ability of the peptoid microspheres to robustly attach glass 
surfaces that have a relative negative charge. The surface zeta potential of the peptoid 
microspheres showed a drastic increase as compared to the ultraclean glass (Figure 3.4). The 
difference between the unmodified surface and peptoid-coated substrate indicates that the surface 
of the peptoid microspheres are positively charged. Although aqueous feed at neutral pH was 
used (~7.0), the amine side chain can be protonated (-NH3+) resulting in a net positive charge. [45] 
An increase in zeta potential as the peptoid chain length increases (12mer = +11.85, 18mer = 
+28.79, 24mer = +41.64) is potentially due to an increase in the number of cationic side chains, 
Figure 3.3 SEM images of (A) 12mer, (B) 18mer, and (C) 24mer peptoid microspheres. The 
size distribution for (D) 12mer, (E) 18mer, and (F) 24mer was evaluated using ImageJ 
software. 
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3.3.4 Differential Scanning Calorimetry Measurements 
The thermal behavior of the peptoid microspheres was examined by differential scanning 
calorimetry (DSC) to measure the excess heat capacity as a function of temperature. DSC was 
run in solid state for the 12mer, 18mer, and 24mer peptoid microspheres to determine the 
thermodynamic properties of thermally induced phase transitions such as melting temperature 
(Tm), enthalpy in terms of endothermic vs. exothermic peptoid degradation, and the polymorphic 
nature of the material. As expected, the heat flow was negative for all three peptoid samples, 
suggesting that the peptoid microsphere degradation occurs endothermically as the peptoid 
microspheres require heat to break the interactions and bonds during phase transition. [46, 47] The 
phase transition temperature increases as peptoid chain length increases, indicating a correlation 
between peptoid helicity and thermal stability (Figure 3.5). The 24mer peptoid microspheres had 
Figure 3.4 Zeta potential measurements for control (4:1 ethanol:water), 
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the highest melting temperature on average at 82.94 ± 0.3845 °C, while the 12mer and 18mer 
peptoid microspheres were similar at 74.00 ± 4.121 °C and 75.22 ± 4.121 °C, respectively. The 
broadness in the DSC peaks indicate that the samples are forming polymorphic structures, 
similar to many common polymers and other microspheres, and at the melting temperature, over 
50% of the sample has undergone a phase transition. [48, 49] 
 
 
3.3.5 Coating Robustness under Biological Assay Conditions 
In order to be practical in biomedical applications, the 12mer peptoid microsphere 
coatings must be robust under various conditions. It was previously observed that the 
Figure 3.5 Differential Scanning Calorimetry measurements for control (4:1 
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microsphere coatings degrade when exposed to ultrapure water for 24 hours [30], therefore a 
thorough investigation was completed to determine whether pH, ionic concentration, or a 
combination of the two were responsible. The robustness of 12mer peptoid microsphere coatings 
was assessed by incubating the coatings in solutions with varying values of pH and ionic 
strength, including casein in PBS for 1 hour, 0.05% Tween in PBS for 12 hours, 0.003% 
hydrogen peroxide in 0.1M sodium borate for 10 minutes, and nanopure water for 10 minutes. 
The microsphere coatings showed minimum degradation, as assessed by morphology and surface 
coverage, in all solutions except water (Figure 3.6A-C and Figure S3.2 in Supplemental 
Information). After exposure to water for 30 minutes the microspheres appeared to disintegrate 
and lift from the surface. Despite the instability of the peptoid microspheres in water, they are 
robust in PBS for up to 2 months (Figure S3.3 in Supplemental Information). Based on these 
preliminary findings, the effects of pH and ionic strength on peptoid microsphere coating 
robustness has been thoroughly investigated.  
 
3.3.6 Effect of Temperature on Coating Robustness 
The effect of temperature on the 12mer peptoid microsphere coating robustness was 
assessed by visually analyzing the coating morphology following incubation in PBS and 
nanopure water at a physiological temperature of 37 °C for 30 minutes (Figure 3.7). At this 
Figure 3.6 SEM images of the peptoid microspheres coatings (A) before incubation, (B) after 
24 hour incubation in PBS, and (C) after 30 minute incubation in water with inset showing a 
high magnification peptoid microsphere.  
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temperature, the peptoid microsphere coatings withstood degradation in all solutions except 
water. In PBS at 37 °C a small salt layer began forming due to the evaporation and deposition of 
PBS salts on the glass substrate, but the overall sphere morphology was maintained.  After 30 
minutes of incubating in water at 37°C, the microspheres began swelling and lifting from the 
surface and overall surface coverage was diminished.  
 
3.3.7 Effect of pH on Coating Robustness  
The effect of solvent pH on the 12mer peptoid microsphere coating robustness was 
studied by assessment of coating morphology and coverage following incubation in PBS (Figure 
3.8) with varying pH. Coatings exposed to solutions with pH of 7 or greater are robust, with no 
significant differences in microsphere morphology or coating coverage (Figures 3.8A-8E). As 
the solvent starts to approach acidic conditions (pH less than 7), the microsphere morphology 
and coating coverage deteriorate (Figures 3.8F-8I). These observations are consistent in both 
PBS and water solutions at similar pH values. These studies were confirmed with water-based 
solutions (Figure S3.4 in Supplemental Information). While we do not anticipate changes in pH 
of the solvent to change the charge state of the peptoids, solubility is increased under acidic 
conditions. [50] Peptoids with ionizable side chains have been demonstrated to destabilize in 
Figure 3.7 SEM images of 12mer peptoid microsphere coatings (A) before incubation (B) 
after 30 minute incubation in PBS at 37 °C, and (C) after 30 minute incubation in nanopore 
water at 37 °C. 
  
 39 
response to pH-dependent changes in aqueous solvents. [11, 51] In aqueous solvents, the 
supramolecular structure of the peptoid is ultimately determined by interactions between the side 
chains and water. In general, polar and charged groups are located on the outside surface due to 
their stabilization with water, while the hydrophobic residues tend to favor the inside of the 
structure. [52] The charged and polar residues, specifically lysine in the case of the peptoids 
studied here, help maintain the solvation necessary to form specific supramolecular structures. 
Therefore, at higher pH values the pKa of the lysine-like side chain is stabilized by being 
unprotonated or neutrally charged, maintaining an optimal solvation effect allowing the peptoid 
microspheres to be robust or less soluble under basic conditions.[53]  At low pH (>7) the lysine 
side chains are below the isoelectric point resulting in a protonated amine group. The protonation 
forms an energetically less favorable charge solvation structure that results in the destabilization 
and increased solubility ultimately leading to the deterioration of the peptoid microspheres. [54] 
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3.3.8 Effect of Ionic Strength on Coating Robustness  
The effect of ionic strength on 12mer peptoid microsphere coating robustness was 
visually assessed by SEM following incubation in various ionic strength solutions (0-500 mM) at 
pH 6.7 (Figure 3.9). SEM images demonstrate there is no considerable effect on microsphere 
morphology at ionic strengths greater than 150 mM (Figures 3.9A-9C). For ionic strength less 
than 150 mM, microsphere morphology and coverage showed signs of degradation (Figures 
3.9D-9F). Specifically, the microspheres appear to fuse together and detach from the surface at 
ionic strengths less than 100 mM.  
Figure 3.8 SEM images of 12mer peptoid microsphere morphology after 30 minutes in PBS 
with pH values of (A) 11, (B) 10, (C) 9, (D) 8, (E) 7, (F) 6, (G) 5, (H) 4, or (I) 3.  
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As compared to peptide helices, peptoid helices are much more stable when under harsh 
conditions. As a result, helical peptoids have been demonstrated to be less susceptible to 
degradation when exposed to various solvent environments (e.g. 2,2,2-trifluorethanol, methanol, 
and concentrated urea) and high temperatures. [18] However, increasing the ionic strength of the 
solvent has been demonstrated to stabilize secondary structure for a variety of ionic polypeptides 
due to screening the electrostatic repulsion between side chains. [55, 56, 57]
 
Strongly charged helical 
peptides are completely destabilized in low ionic strength environments. [58] A similar 
dependence has been observed in high-ionic strength solutions for peptoids. [18, 51] It is 
hypothesized that the screening of charge-charge repulsive interactions at higher ionic strengths 
preserves the helical secondary structure that is crucial for microsphere formation. The 
Hofmeister series claims that based on the presence of specific ionic compounds there can be a 
salting “in” or “out” effect that changes the hydrophobicity of the solvent composition, 
ultimately changing the macromolecules’ optical activity and secondary structure. [59, 60, 61]   
Figure 3.9  SEM images demonstrating the effect of ionic strength on sphere morphology 
after 30 minutes incubation in water solutions with ionic strengths of (A) 500 mM, (B) 250 
mM, (C) 150 mM, (D) 100 mM, (E) 50 mM, and (F) 0 mM.  
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3.4   Conclusion  
In this study we have shown for the first time that peptoid relative helicity affects the size of 
microspheres formed, the relative charge location on the microspheres, as well as evaluated the 
effects of temperature, pH, and ionic strength on the robustness of microsphere coatings. Peptoid 
microsphere size can be tuned by varying relative helicity, or peptoid chain length (increased 
length leads to increased helicity). Increased relative helicity leads to smaller peptoid 
microspheres due to the tight helical secondary structures. Conversely, peptoids with looser 
helical structures form larger microspheres. The chain length, related to size, also effects the 
surface charge, as increased chain length had a higher surface zeta potential than the shorter 
chains. The phase transition temperature for the microsphere coatings increased as the peptoid 
chain length increased, pointing towards a stability conundrum between helicity and degradative 
resistance. Future studies will be performed to determine the overall number of peptoid 
molecules per microsphere, or packing density, using Small Angle X-ray Scattering and Small 
Angle Neutron Scattering. These current studies have proven that the peptoid microsphere 
coatings are robust at physiological conditions, as well as high pH and ionic strength solutions. 
However, under acidic conditions or at low ionic strengths the coatings deteriorate. The ability to 
tune peptoid microsphere size, as well as stability at physiological conditions, make peptoid 
coatings promising for use in biosensors and other biomedical applications. 
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Abstract 
Enzyme-linked immunosorbent assay (ELISA) microarray performance is limited by low assay 
sensitivity and dynamic range. Increasing the surface area for reagent binding can help to 
improve performance, but standard techniques such as roughening the surface or adding a 
polymer coating lead to increased non-specific fluorescence and do not have reproducibly 
improved performance. Another approach to increase surface area is adding a microsphere 
coating on the surface. Poly-N-substituted glycine (peptoid) microspheres are ideal for this 
application due to low immunogenicity, protease-resistance, and biocompatibility. Peptoids are 
polymers with a backbone similar to peptides, but with the side chains appended to nitrogen 
rather than the alpha carbon. A variety of side chain chemistries can be incorporated into 
peptoids through a solid-phase, sequence-specific synthesis protocol. Here we report the 
development of sandwich ELISA microarray on peptoid microsphere coated glass slides. Coating 
morphology was evaluated via SEM and efficacy was assessed by ELISA microarray 
performance. Peptoid microsphere coated glass slides exhibit an increase in signal intensity and 
dynamic range as compared to commercially available microarray slides. These studies show the 
potential for peptoid microspheres as coatings for ELISA microarray slides, as well as for use in 
other biosensor applications.   
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4.1 Introduction  
Over the last several decades there have been numerous publications focused on the 
development of sensitive, disease-specific assays to assist in therapeutic decisions [76, 77, 78, 
79, 80]. Early disease detection decreases economic costs, improves treatment options, and 
reduces mortality [6]. Biomarker-based technologies, including enzyme-linked immunosorbent 
assay (ELISA) microarray and bead-based immunoassay, offer platforms for sensitive and 
specific disease detection [7]. Multiplex bead array assays (MBAA) such as Luminex, xMap [8], 
Smartbead UltraPlex [9], and flow cytometry technologies [10] offer promising, high-throughput 
methods of detecting cytokines and other analytes in serum and plasma samples. MBAAs make 
it possible to perform immunoassays in a multiplexed design to independently and qualitatively 
analyze multiple samples at one time. For instance, the xMAP technique utilizes hundreds of 
uniquely colored beads, ranging from much larger magnetic beads (6.5 µm) to smaller non-
magnetic beads (~1 µm), created by two different fluorescent dyes to simultaneously identify 
multiple analytes [8]. However, a key concern in the viability of MBAAs is the potential for 
interference between analyte samples. The antibodies on each bead may cross-react with other 
antibodies, cross-species antibodies, and molecules, ultimately reducing the efficacy of the 
MBAA techniques and requiring additional testing to ensure no cross-reacting has occurred [11].  
ELISA microarray technology has emerged as a strong platform for the analysis of 
biomarkers due to its ability to quantify low-abundance proteins in complex biological fluids 
over large concentration ranges [12,2]. ELISA microarray eliminates the cross-reactivity that is 
commonly seen in MBAAs by focusing on a single analyte at a time. The use of matched high-
affinity antibody pairs to target a single antigen results in unmatched sensitivity and specificity. 
The miniature scale of the platform allows for cost-effective and efficient parallel screening of 
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small sample volumes in a high-throughput manner [12]. The slide chemistry and morphology is 
crucial for optimal performance of ELISA microarray, as is evident by the large number of slide 
chemistries commercially available [13, 14, 15, 16, 17, 18, 4]. The slides must allow antibodies 
to be immobilized in a manner that maintains protein binding affinity while retaining high 
binding capacities, high signal-to-noise ratios, and high reproducibility [19]. Additionally, the 
high-throughput nature of the platform requires substrates to be robust and retain high levels of 
specificity and sensitivity through rigorous processing conditions and prolonged storage periods. 
While poly-L-lysine slides have emerged as promising slide chemistry due to strong antibody 
attachment via adsorption and high signal-to-noise ratio [20, 21], ELISA microarray 
performance can be further improved by increasing the surface area for antibody attachment. In 
theory, increasing the surface area for antibody attachment should enhance the microarray results 
by providing more sites of attachment to increase signal intensity and the dynamic range. 
Polymer-based surfaces that increase surface area such as polyacrylamide [5, 22], agarose [23], 
and nitrocellulose [24, 25, 26, 27, 28] suffer from low signal-to-noise ratios due to absorption of 
protein in the porous coating [20, 21].  
Poly-N-substituted glycines (peptoids) are promising as coatings for microarray slides 
due to their low immunogenicity, ease of synthesis, variety of available side chain chemistries, 
and the ability to form supramolecular structures that can increase surface area [29]. Peptoids are 
bioinspired, peptidomimetic polymers with a backbone structure closely resembling that of 
peptides, but with the side chains appended to the amide groups rather than the alpha-carbons. 
This structural modification prevents proteolytic degradation, making peptoids attractive as 
biocompatible materials. However, this modification also removes the presence of backbone 
amide hydrogens, which are critical for the formation of the hydrogen bond linkages that 
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stabilize beta sheets and helices in peptides. Introduction of steric hindrance through side chain 
chemistry allows for the formation of secondary structures including turns [30, 31], loops [32], 
and helices [33, 34, 35, 36, 37], as well as supramolecular assemblies such as superhelices [38], 
nanosheets [39], nanotubes [40], and microspheres [41].  
Our lab has previously shown that partially water-soluble, helical peptoids self-assemble 
into microspheres [37] and can form uniform surface coatings [44]. The peptoid sequence, 
referred to as P3 (Figure 4.1), includes chiral, aromatic side chains on two faces of the helix to 
induce the formation of helical secondary structure [41].  The third face of the helix, which offers 
considerable flexibility of design, contains methoxy and amine groups to increase water 
solubility. The amine groups enable covalent linkage to and electrostatic interactions with the 
slide surface. The secondary structure of P3 was determined by circular dichroism, which 
confirms polyproline type-I-like secondary structure [35].  
 
In this study, we report the development of peptoid microsphere coated glass substrates for 
use in sandwich ELISA microarray. The morphology and uniformity of the coatings was 
evaluated by SEM and the coating efficacy was analyzed by ELISA microarray with known 
antibody pairs. The peptoid microsphere coated surfaces were found to exhibit higher signal 
intensity and dynamic range as compared to commercially available microarray slides. 
Figure 4.1 Peptoid structure for the P3 sequence. 
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4.2  Materials and Methods 
4.2.1 Materials 
4-methoxybenzylamine and (S)-methylbenzylamine were purchased from Acros 
Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl) carbamate was purchased from 
CNH Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from 
NovaBiochem (Gibbstown, NJ). Piperidine was purchased from Sigma-Aldrich (St. 
Louis, MO). Test grade silicon wafers were purchased from University Wafer (South 
Boston, MA). Poly-L-lysine and ultra clean glass microarray slides were purchased from 
Thermo Scientific (Pittsburgh, PA). Disuccinimidyl suberate (DSS) and 
bis[sulfosuccinimidyl] suberate (BS3) were purchased from Pierce (Rockford, IL, USA). 
Purified antibodies and antigens were purchased from R&D Systems (Minneapolis, MN, 
USA). Blocking solution containing 10 mg/ml casein in phosphate-buffered saline, pH 
7.2 (PBS) was purchased from Bio Rad Laboratories (Hercules, CA, USA). Tyramide 
Signal Amplification (TSA) system, including streptavidin-conjugated horseradish 
peroxidase, amplification diluent, and biotinyl tyramide, was purchased from Perkin 
Elmer (Wellesley, MA, USA). Alexa647-conjugated streptavidin was purchased from 
Invitrogen Life Technologies (Gaithersburg, MD). All other reagents were purchased 
from VWR (Radnor, PA). Chemicals were used without further modifications unless 
otherwise specified.  
4.2.2 Peptoid Synthesis 
Peptoids were synthesized via the submonomer solid-phase method on rink amide 
resin, as previously described [42]. Briefly, the resin was swelled with 
dimethylformamide (DMF) and the Fmoc protecting group was removed using a 20% 
solution of piperidine in DMF. The resin-bound secondary amine was acylated with 0.4 
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M bromoacetic acid in DMF in the presence of N,N’-diisopropyl carbodiimide. Amine 
submonomers were incorporated via an SN2 nucleophilic substitution reaction with 
primary amine in DMF. The two-step bromoacetylation and nucleophilic substitution 
cycle was repeated until all desired side chains were incorporated. The peptoid was 
cleaved from the resin using a mixture of 95% trifluoroacetic acid (TFA), 2.5% water, 
and 2.5% triisopropylsilane, and the acid was removed using a Heidolph Laborota 4001 
rotary evaporator (Elk Grove Village, IL). The peptoid was lyophilized to a powder using 
a Labconco lyophilizer (Kansas City, MO) and diluted to a concentration of ~3 mg/ml in 
a 50:50 acetonitrile-water solution.  
4.2.3 Peptoid Purification 
Peptoids were purified using a Waters Delta 600 preparative high-performance 
liquid chromatography (HPLC) instrument (Milford, MA) with a Duragel G C18 150 × 
20 mm column (Peeke Scientific, Novato, CA) and a linear gradient of 35-95% solvent B 
(acetonitrile, 5% water, 0.1% TFA) in A (water, 5% acetonitrile, 0.1% TFA) over 60 
minutes.  Peptoids were confirmed to be >98% pure via analytical HPLC (Waters 
Alliance, Milford, MA) with a Duragel G C18 150 × 2.1 mm column (Peeke Scientific) 
using a linear gradient of 35 to 95% solvent D (acetonitrile, 0.1% TFA) in C (water, 0.1% 
TFA) over 30 minutes. Purified peptoid fractions were lyophilized and stored as a powder 
at -20 °C. 
4.2.4 Peptoid Characterization 
Synthesis of the desired peptoid sequence was confirmed via matrix assisted laser 
desorption/ionization time of flight mass spectrometry (MALDI-TOF; Bruker, Billerica, 
MA). Secondary structure was confirmed via CD spectrometry using a Jasco J-715 
instrument (Easton, MD) at room temperature with a scanning speed of 20 nm/min and a 
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path length of 0.1 mm. The peptoid was dissolved in methanol at a concentration of 120 
µM. Each spectrum was the average of twenty accumulations. 
4.2.5  Peptoid Microsphere Coatings 
Peptoid microspheres were prepared by dissolving the peptoid in a 4:1 (v/v) 
ethanol/water solution at a concentration of 5 mg/ml, as previously described [41]. Glass 
slides (Erie Scientific, Portsmouth, NH) were outlined with an 8 x 2 array pattern using a 
Barnstead Thermolyne microarray slide imprinter (Dubuque, IA) to create a hydrophobic 
barrier for processing 16 wells per slide. The peptoid solution was applied to the glass 
surfaces and allowed to dry at room temperature and 60% relative humidity. Coating 
morphologies were visually assessed using a Phillips XL-30 scanning electron 
microscope (SEM; FEI, Hillsboro, OR).  
4.2.6 Microsphere Surface Density Distribution 
Microsphere surface density distribution of the microsphere coatings was 
calculated using ImageJ software (National Institute of Health, MD). Noise reduction was 
completed with a fast Fourier transform (FFT) band-pass filter normalization, eliminating 
low- and high-spatial frequencies and transforming the original SEM images to a two-
dimensional representation of the frequency. The images were converted to 8-bit 
grayscale and binarized adjusting the white and black threshold to optimize particle 
contrast with the background. Particle analysis was completed on the adjusted images to 
give an area percentage for the microsphere particles.   
4.2.7 Microarray Printing 
ELISA microarray printing was performed at room temperature and 60% relative 
humidity as previously described [20]. Briefly, a GeSiM NanoPlotter 2.1 non-contact 
microarray printer with humidity control (Quantum Analytics, Foster City, CA, USA) 
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was used to spot the antibodies. Prior to spotting, the microsphere coated surfaces, and in 
some cases the poly-L-lyisne slides, were treated with a 0.3 mg/ml solution of the homo-
bifunctional cross-linker BS3 in PBS for 20 minutes to create a reactive site for covalent 
attachment of antibodies via the amine groups. After incubation, the slides were rinsed in 
nanopure water and dried in a centrifuge. Capture antibodies were suspended in PBS to a 
concentration of 0.8 mg/ml and ~400 picoliters per spot were printed 500 μm apart in 
quintuplicate on each array. Upon completion, the antibodies were allowed to dry for an 
additional hour at 60% relative humidity. The slides were blocked with 10 mg/ml casein 
in PBS and processed immediately.  
4.2.8 ELISA Microarray  
ELISA microarray was performed as previously described [20]. Briefly, all 
incubation steps were performed at room temperature in a closed, dark, humid chamber, 
with gentle mixing on an orbital shaker (Belly Dancer, Stovall Life Science, Greensboro, 
NC). A two-step wash procedure between processing steps was performed by submerging 
the slides twice into PBS containing 0.05% Tween-20 (PBS-T). The slides were 
incubated with a mixture of antigen standards in 1 mg/ml casein in PBS overnight. 
Standard curves were created using a three-fold dilution series of the antigen mix along 
with an antigen-free blank for twelve total dilutions. Following a wash cycle, the slides 
were incubated with biotinylated detection antibody at 25 ng/ml in 1 mg/ml casein in 
PBS. The biotin signal was amplified using the TSA system following manufacturer 
instructions, and incubated with 1 μg/ml Alexa647-conjugated streptavidin in PBS-T. 
The slides were rinsed twice in PBS-T followed by deionized water. 
A GenePix Autoloader 4200AL laser scanner (Molecular Devices, CA) was used 
to image the Alexa 647 fluorescence signal. The spot fluorescence intensity from the 
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scanned slide images was quantified using GenePix Pro 3.0 software. Standard curves 
were created using ProMAT, a software program specifically developed for the analysis 
of ELISA microarray data based on a four-parameter logistic curves model [43]. The 
values for the lower limits of detection are calculated as the median concentration of the 
antigen-free blank plus three standard deviations [45]. In order to provide a value that is 
representative of all assays for comparisons, a relative limit of detection value was 
calculated using the median value for all assay replicates on each surface, as previously 
described [20]. Unless noted otherwise, results shown encompass three replicate 
experiments performed using slides that were coated, printed, and processed on 
independent occasions.  
4.3 Results and Discussion 
4.3.1 Coating Characterization 
The formation of uniform peptoid microsphere coatings is essential to reduce 
variability in ELISA microarray. Coating morphology is directly linked to evaporation 
rate, requiring careful monitoring of drying conditions to ensure uniform sphere 
distribution and reproducible coatings. One issue observed in the formation of peptoid 
coatings is perimetral intensive deposition, often referred to as the “coffee ring effect,” in 
which denser coverage is observed at the perimeter of the coatings as compared to the 
center. Previous studies have shown that this effect is reduced when samples are 
evaporated at a constant contact area, which can be achieved by including surfactant in 
the microsphere solution [46].  The addition of Tween-20 to the peptoid microsphere 
solution results in improved coating uniformity, lessening perimetral microsphere 
deposition and allowing for an even distribution of microspheres on the surface (Figure 
4.2). At concentrations >0.1%, Tween-20 disrupts microspheres formation and alters 
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microsphere size distribution (Figure S4.1 in Supplemental Information). Previous work 
in our lab has focused on the reproducibility of the coatings, the physical properties of the 
microspheres, and their ability to withstand various conditions (pH, ionic strength, 
solvents) [36][47]. Using ImageJ particle analysis of SEM images, the average local 
microsphere surface density (n=10) on the glass slides was 87% (s=2.59%) covered 
(Figure S4.2 in Supplemental Information).  
 
When antibodies were spotted directly on the peptoid microsphere coated slides, 
faint fluorescent signals were observed indicating weak adsorption of the antibodies to 
the surface. The homobifunctional linker, BS3, was used to covalently attach the 
antibodies to the peptoid microsphere coated slides (Figure 4.3A).  ELISA microarray 
results were reproducible for the slides with covalently attached antibodies. It should be 
noted that antibodies were not covalently attached to the poly-L-lysine surfaces because 
both our results (Figure 4.3B) and findings by others [20] show no significant difference 
in ELISA microarray performance between adsorbed and covalently attached antibodies. 
 
 
Figure 4.2 Peptoid microsphere coated glass surfaces at (A) 3500x and (B) 1000x 
magnifications. Peptoids were dissolved in a 4:1 (v/v) ethanol/water solution at a 
concentration of 5 mg/ml. The peptoid solution was applied to the glass surfaces and 




4.3.2 Coating Efficacy for ELISA Microarray 
The efficacy of the peptoid microsphere coatings was evaluated by ELISA 
microarray with four antibody assays (Table 4.1) that were previously shown to have 
good assay sensitivity and specificity, as well as low cross-reactivity, in multiplexed 
ELISA microarray [3]. The performance of the surfaces was evaluated based on spot 
morphology, signal to noise ratio, limit of detection, and standard curve dynamic range. 
Signal intensities were evaluated by comparing single concentration assays on peptoid 
microsphere coated blocks with poly-L-lysine surfaces. Single point antigen 
concentrations correspond to the third dilution of the three-fold standard curve dilution 
series (i.e., approximately 11% of the maximal concentration), which has previously been 
Figure 4.3 (A) Images of fluorescence for GFP and HGF on peptoid microsphere 
coated glass surfaces with (a) non-covalent treated and (b) BS3 treated covalent 
surfaces. (B) Images of fluorescence for GFP and HGF on uncoated poly-L-lysine 
slides with (a) non-covalent treated and (b) BS3  treated covalent slides.  
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shown to provide a strong signal intensity near saturation and in the upper usable range of 
the standard curve [3].  
Table 4.1 Summary of the results detailing the maximal concentration of antigens, lower 
and upper bound, dynamic range concentrations, and single point signal intensities (11% 
of the maximal concentration) for the ‘uncoated’ poly-L-lysine surfaces and peptoid-
based microsphere coated surfaces antigens for all 4 different assays: CD14 (cluster of 
differentiation 14), GFP (green fluorescent protein), HGF (hepatocyte growth factor), and 
RANTES (regulated on activation normal T cell expressed and secreted). 
 
Spot morphology is dependent on the characteristics of the surface, and as such 
the increased topographical complexity of peptoid microsphere coated surfaces presents 
challenges. Although the spot morphology on peptoid microspheres is not as crisp as 
those on the two-dimensional poly-L-lysine surfaces (Figure 4.3A), they are greatly 
improved over other three-dimensional surfaces [20]. The shape of the spots is still 
detected and analyzed by the GenePix software without any issues.  
As expected, peptoid microsphere coated surfaces consistently displayed stronger 
signal intensities as compared to poly-L-lysine slides (Figure 4.3C and Table 4.1). This 
observation is consistent for all assays independent of whether the comparisons are based 
on a single concentration point (Figure 4.3C) or over the full standard curve (Figure 4.4). 
However, as is the case with other three-dimensional slide surfaces, the peptoid 
microsphere coated surface exhibits higher background fluorescence as compared to the 
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poly-L-lysine surface (Figure 4.3B). Despite the increased background signal, the signal-
to-noise ratio for the peptoid microsphere coating is the same as or higher than the poly-
L-lysine coating (Table 4.1). More specifically, the signal-to-noise ratio is higher on the 
peptoid microsphere coated slides for three of the four assays tested. These data support 
the hypothesis that the use of peptoid microsphere coatings to increase surface area leads 
to improved ELISA microarray properties. 
 
 
The limit of detection is defined as the lowest concentration that can be reliably 
detected and is a direct assessment of assay sensitivity. Evaluation of surface 
Figure 4.4 Standard curves for HGF on uncoated poly-L-lysine slides and peptoid 
microsphere coated surfaces. Results are representative of the trends observed across 
all antibody assays (see Figure S3 in Supplemental Information). Data points and 
cross-bars represent the means and standard deviations, respectively. The standard 
curves encompass data from all three replicate experiments performed using slides 
that were coated, printed, and processed on independent occasions.  
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performance is based on previously published methods, where relative limit of detection 
below 2 is ‘superior’, between 2 and 4 is ‘normal’, and above 4 is ‘poor’ [20]. Despite the 
larger standard deviation observed at low antigen concentration for the peptoid 
microsphere coatings, they are rated in the superior category with a score of 0.9 ± 0.5 as 
compared to a score of 0.8 ± 0.3 for poly-L-lysine slides in our study. These values are 
comparable to published values for commercially available slides including poly-L-lysine 
(0.7 ± 0.1), aminosilane (1.3 ± 0.6), aldehyde silane (1.1 ± 0.4), epoxysilane (1.2 ± 0.6), 
Slide E (0.8 ± 0.4), and Full Moon (1 ± 0.7) [87].  
ProMAT interprets the useful range of the standard curves as that between the 
lower limit of detection and upper concentration bound. As the standard curve for HGF in 
Figure 4 demonstrates, and Table 1 details for all assays, the dynamic range observed for 
the peptoid microsphere coated surfaces is increased as compared to poly-L-lysine 
surfaces (2.4 pg/ml for CD14, 17 pg/ml for GFP, 357.5 pg/ml for HGF, and 199.6 pg/ml 
for RANTES).  
4.4 Conclusion 
Disease detection requires high-throughput assessment of multiple proteins within 
small sample volumes. The use of ELISA microarray and biosensors for disease detection 
will require the development of optimized support surfaces that allow for more generally 
applicable and direct immobilization procedures. While high binding affinities are 
imperative to prevent antibody loss and ensure robust attachment, the challenge lies in 
designing a microarray support that accommodates proteins of varying characteristics and 
provides an environment that preserves the active form of the protein. The use of peptoid 
microsphere coatings as a novel surface for the improvement of sandwich ELISA 
microarray has been evaluated. This peptoid-based, three-dimensional coating offers a 
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customizable, robust, biocompatible interface that increases the surface area available for 
binding. The efficacy of the coating was assessed in terms of its overall ELISA 
microarray performance as compared to commercially available poly-L-lysine surfaces. 
The peptoid microsphere coated surfaces allowed for strong covalent antibody attachment 
and performed well in terms of spot morphology, signal to noise ratio, limit of detection, 
and standard curve dynamic range. The increase in surface area enables higher protein 
binding capacities as compared to poly-L-lysine surfaces, and although the peptoid 
microsphere coatings displayed higher background fluorescence and coefficients of 
variation the signal-to-noise ratios were higher as compared to poly-L-lysine surfaces. 
Furthermore, the limits of detection were comparable to the poly-L-lysine surfaces and an 
improvement in dynamic range was observed for all assays tested. 
The peptoid microsphere coatings provide an exciting new interface for a wide 
range of biosensor applications. Results suggest that commonly used biosensor protocols 
and procedures can be readily applied to peptoid microsphere coatings, and that the 
coatings outperform state-of-the art surfaces such as poly-L-lysine. The robust peptoid 
microsphere coated surface provides a versatile platform that can be easily customizable 
to allow for various surface chemistries and incorporate different attachment sites. It 
offers the benefits that come with an increased surface area for binding, while at the same 
time allow for use of familiar chemistries that are established for both protein microarray 
and biosensor applications.  
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Figure S4.1 Effects of Tween-20 on microsphere coatings: A) 0.001%, B) 0.01%, C) 
0.1%, and D) 1% by volume. 
 
Figure S4.2 The surface coverage density was calculated using ImageJ particle analysis 
of A) SEM images of peptoid microsphere coatings and B) processed 8-bit binary 








Figure S4.3 Standard curves for all 4 antibody assays (CD14, GFP, HGF, and RANTES) 













5. Peptoid Microsphere and Polyelectrolyte Multilayer Fabrication for Cell 
Culture Applications 
5.1 Introduction  
Naturally occurring polymers, specifically proteins and peptides, have beneficial 
fundamental features that make them ideal candidates for biomedical applications [1]. 
However, these proteins and peptides are susceptible to proteolytic degradation and often 
have low bioavailability [161, 19]. Researchers are increasingly turning to synthetic 
polymers, or peptidomimetic oligomers, that emulate the function of naturally occurring 
polymers, but have increased resistance to enzymatic degradation [161, 87]. One class of 
peptidomimetic oligomers, peptoids or poly-N-substituted glycines, closely resemble the 
structure of peptides with the side chains attached to the backbone amide groups rather 
than the alpha-carbon as in peptides [162]. This structural modification creates an achiral 
backbone and eliminates the hydrogen bond donors, both of which are necessary for 
forming secondary structures. By including chiral, aromatic side chains to the peptoid 
sequence a helical secondary structure can be induced. Peptoid synthesis involves using a 
solid phase “sub-monomer” method that allows for the precise construction of a diverse 
polypeptoid sequence library [163]. Thus, making peptoids an attractive candidate for 
biomaterial development and therapeutic applications.  
Biomimetics have gained traction for use as artificial extracellular matrix (aECM) 
components in tissue engineering. The natural extracellular matrix is a complicated 
network of various biomacromolecules that includes proteins, polysaccharides, and 
glycoproteins [7].  The goal for these biomimetic materials is to generate scaffolds that 
directly mimic the natural tissue’s biomechanical and chemical properties to incite 
cellular adhesion, growth, and survival for potential in tissue repair and disease treatment. 
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The aECM scaffolds must be three-dimensional to fully mimic the complicated ECM 
network [8]. Nevertheless, little is known on the direct effect that the topography and 
spatial arrangement of aECM structural features have on stem cell fate.  
The layer-by-layer (LbL) formation of polyelectrolyte multilayers (PEMs) utilizes 
the ionic attraction between oppositely charged materials to alternate the adsorption of 
anionic and cationic polyelectrolytes [9]. The ability to tune the chemical, physical, and 
topographical properties of the LbL deposition by altering the pH, ionic strength, number 
of layers, and layer thickness makes them ideal candidates for tissue engineering, 
biosensors, and drug delivery applications [10]. LbL films can be assembled using 
naturally occurring and synthetic polymers, creating a vast library of potential polymers 
[11]. For example, heparin is an essential polysaccharide found in the ECM and has been 
utilized in LbL depositions for enhanced cellular activity. Heparin is known to regulate 
cell proliferation, cellular adhesion, matrix assembly, and would healing [12, 13]. Poly-L-
lysine (PLL) is a cationic, homopolypeptide consisting of repeated positively charged L-
lysine residues. PLL solutions are commonly coated on cell culturing substrates to help 
enhance cell adherence and cell viability [14]. Therefore, LbL films constructed from 
heparin and PLL layers makes an interesting candidate as a bioactive substrate for stem 
cell culturing.  
Our lab has previously shown that partially water-soluble, helical peptoids self-
assemble into microspheres [15] and can form uniform surface coatings [16]. The peptoid 
sequence (Figure 1.3) includes chiral, aromatic side chains on two faces of the helix to 
induce the formation of helical secondary structure.  The third face of the helix offers 
customizability, contains methoxy and amine groups to increase water solubility. The 
amine groups provide a positive surface charge to the microspheres allowing for  
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attachment to glass slides and other adducts. The positive charge can serve as an anchor 
for LbL development to build thin films of polymers across the surface of the peptoid 
microspheres. The customizability of the microsphere chemistry allows for fine-tuning 
based on the desired application.  
 
In this study, we discuss the addition of heparin and poly-L-lysine LbL films to the 
peptoid microspheres for potential applications as an aECM substrate. The morphology 
and uniformity of the coatings were evaluated by SEM and 3D Laser Scanning 
Microscopy. The chemical composition of the coatings was analyzed by FTIR. The 
peptoid microsphere and HEP/PLL coated surfaces were found to be biocompatible and 
non-cytotoxic with primary cortical rat astrocytes.































5.2 Materials and Methods 
5.2.1 Materials  
  (S)-methylbenzylamine and 4-methoxybenzylamine were purchased from Acros 
Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl)carbamate was purchased from CNH 
Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from NovaBiochem 
(Gibbstown, NJ). Piperidine, N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC), and N-hydroxysulfosuccinimide sodium salt (Sulfo-NHS), and poly-L-lysine 
hydrobromide (mol wt 30,000-70,000) was purchased from Millipore-Sigma (St. Louis, MO). 
Ultra clean glass microarray slides and disuccinimidyl suberate (DSS) were purchased from 
Fisher Scientific (Pittsburgh, PA). All other reagents were purchased from VWR (Radnor, PA). 
All chemicals were used without further modifications unless otherwise specified.  
5.2.2 Peptoid Synthesis, Purification, and Characterization 
The peptoid was synthesized following a submonomer, solid-phase method on rink amide 
resin at room temperature [163].  The synthesis follows two steps: (1) acylation, which adds an 
activated carboxylic acid derivative onto a receptive amine generating the backbone of the 
peptoid, and (2) amination, the nucleophilic displacement by a primary or N-terminal secondary 
amine (side chain). The Fmoc-protection group was removed from the resin using 20% 
piperidine/DMF for 12 minutes creating a resin-bound amine. The resin was acylated with 0.4 M 
bromoacetic acid in DMF (4.25 mL) and N,N’-diisopropyl carbodiimide (0.8 mL), mixing for 1 
minute.  The amine submonomers were added to the resin at a concentration of 1.0 M via a 
nucleophilic substitution reaction for a period of 2 minutes. The two-step acylation and 
nucleophilic substitution cycle was repeated until the desired sequence was obtained. The resin 
was washed with DMF (4 x 5mL) after each step and with dicholoromethane (DCM) (3 x 5 mL) 
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after the last submononer was added. The peptoid was cleaved from the resin using a mixture of 
95% trifluoroacetic acid (TFA), 2.5% water, and 2.5% triisopropylsilane for 10 minutes prior to 
evaporating the acid off using a Heidolph Laborota 4001 rotating evaporator (Elk Grove Village, 
IL). 
The peptoid was dissolved in a 3 mg/mL solution of acetonitrile and water. The peptoid 
was purified using a Waters Delta 600 preparative high-performance liquid chromatography 
(HPLC) instrument (Milford, MA) with a Duragel G C18 150 × 20 mm column (Peeke 
Scientific, Novato, CA) and a linear gradient of 35-95% solvent B (acetonitrile, 5% water, 0.1% 
TFA) in A (water, 5% acetonitrile, 0.1% TFA), over 60 minutes.  Peptoids were confirmed to be 
>98% pure via analytical HPLC (Waters Alliance) with a Duragel G C18 150 × 2.1 mm column 
(Peeke Scientific) using a linear gradient of 5-95% solvent B (acetonitrile, 0.1% TFA) in A 
(water, 0.1% TFA), over 30 minutes. Presence of the desired sequence was confirmed via matrix 
assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry (Bruker, 
Billerica, MA). Purified peptoid fractions were lyophilized and stored as a powder at -20 °C. 
5.2.3  Peptoid Microsphere Coatings  
In order to create a covalent binding site on the ultraclean glass slides, they were 
pretreated with the homo-bifunctional cross-linker, disuccinimidyl suberate (DSS). The DSS (30 
mg) was dissolved in DMF (1 mL) and diluted with HPLC-grade methanol (150 mL) to form a 
final concentration of 0.2 mg/mL. The DSS solution was applied to the ultraclean glass slides for 
5 minutes at room temperature by dipping the slides in the solution using a slide rack and 
incubation chamber. The glass slides were rinsed twice with methanol and dried using a 
centrifuge at 500 RPM for 30 seconds. Peptoid microspheres were prepared by dissolving the 
peptoid in a 4:1 ethanol/water (v/v) solution at a concentration of 3 mg/mL. The peptoid 
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microsphere solution was drop casted onto the DSS treated glass slides using a pipette and 
allowed to dry at room temperature and 60% relative humidity for 1 hour. The coating 
morphology was characterized using a Phillips XL-30 environmental scanning electron 
microscope (SEM; FEI, Hillsboro, OR). 
5.2.4 Preparation of Polymeric Multilayers on Peptoid Microspheres 
HEP and PLL were used to prepare polymeric multilayers on ultraclean glass slides and 
peptoid microsphere coated substrates using the LbL technique. The HEP/PLL multilayers were 
deposited on the substrates for a combination of 0.5, 1.0, 3.0, and 3.5 bilayers. The ultraclean 
glass substrates were treated with poly(ethylenimine) (PEI) dissolved in HEPES buffer (pH 7.4) 
for 15 minutes to provide an anchor, or strongly positive layer on the surface. The positive 
surface charge of the peptoid microsphere coatings was utilized in applying the first anionic 
heparin layer. Both HEP and PLL polymers were dissolved to 1 mg mL-1 in HEPES buffer (pH 
7.4), which was also used as the washing solution. We evaluated layers of HEP/PLL ending in 
either HEP or PLL for a combination of 0.5 (HEP only), 1.0, 3.0, and 3.5 bilayers. HEP and PLL 
were deposited on the glass or peptoid microsphere substrate by pipetting the polymer solution 
onto the substrate and incubating for 5 minutes per layer with a 3-minute wash in HEPES buffer 
in between. After the desired number of layers was achieved, the substrates were washed with 
HEPES for 5 minutes and centrifuged at 500 RPM for 30 seconds to dry. To promote cellular 
adhesion, the PEMs were cross-linked overnight with EDC at 10 mg/mL and Sulfo-NHS at 11 
mg/mL dissolved in HEPES buffer. After 24 hours, the samples were washed with HEPES buffer 
three times and dried using the centrifuge at 500 RPM for 30 seconds. The PEM samples were 
stored at 4°C until needed.    
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5.2.5 Coating Morphology and Uniformity 
The surface topographies of the peptoid microsphere and HEP/PLL coatings were 
investigated using a Keyence VK-X260K 3D laser scanning confocal microscope. This 
microscope allows for the three-dimensional analysis of the surface without harming the 
samples. The images were taken using a 100x objective lens and a surface map was created by 
scanning the surface of our samples.  
The morphology of the peptoid microsphere and HEP/PLL surfaces was analyzed using a 
Phillips XL-30 scanning electron microscope (SEM; FEI, Hillsboro, OR). The peptoid 
microsphere coatings were imaged to ensure successful coating of the microspheres prior to 
applying the LbL films. Once fabricated, the peptoid microsphere and HEP/PLL coatings were 
analyzed using SEM. The samples were sputter-coated with gold prior to imaging to remove 
charged electrons from the material and decrease the signal-to-noise ratio allowing for higher 
quality images to be captured.  
5.2.6 Astrocyte Culturing  
Primary cortical rat astrocytes were previously isolated and expanded from 1-day old 
neonatal rats and were cryopreserved for future testing [17]. For use in cell viability studies, the 
cryopreserved astrocytes were thawed, plated onto tissue culture treated flasks, and expanded to 
desired growth numbers in cell growth media consisting of Dulbecco’s Modified Eagle Medium 
F12 Formulation (DMEM/F12) supplemented with 10% fetal bovine serum (FBS). The 
astrocytes were incubated at 37 °C, 95% humidity, and 5% CO2. Prior to seeding, the peptoid 
microsphere, LbL, glass control, and fibronectin controls were prepared and transferred to a 12 
well plate for testing. The glass for the control samples was sterilized and prepped by sonicating 
the ultraclean glass slides in ethanol for 5 minutes, drying in the oven at 70 °C, and treating with 
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UV/ozone for 30 minutes. The positive control sample was prepared by adding 50 µL of a 40 µg/ 
µL fibronectin in sterile distilled water solution. The expanded astrocytes were detached from 
the culture surface using trypsin supplemented with EDTA (0.25%), counted with the 
hemocytometer, and seeded on the substrates at a cell density of 1 x 105 cells per sample. The 
astrocyte seeded substrates were incubated for 72 hours to facilitate astrocyte attachment and 
growth.  
5.2.7 Cell Viability Assay  
The cell viability was assessed using a Live/Dead® Viability/Cytotoxicity Kit that utilizes 
green-fluorescent calcein-AM and red-fluorescent ethidium homodimer-1. After 72 hours of 
culturing, the media was removed from the cell cultures and the samples were washed with 
Dulbecco’s phosphate-buffered saline (D-PBS). A solution of 2 µM calcein and 4 µM ethidium 
homodimer-1 in D-PBS was added to the samples for 30 minutes. The live/dead stains were 
removed and the cells were imaged with a fluorescence microscope. The live cells were observed 
with a fluorescein isothiocyanate (FITC) filter and the dead cells were observed with a 
tetramethylrhodamine isothiocyanate (TRITC) filter. The live and dead images were overlaid and 
analyzed using ImageJ software.    
5.3 Results and Discussion 
5.3.1 Coating Characterization  
SEM confirmed the uniformity and morphology of the peptoid microsphere coatings on 
the glass surfaces (Figure 5.1). From a previous study, the average local microsphere surface 
density (n=10) on the glass slides was 87% (s=2.59%) covered. The LbL films were then 
deposited on the peptoid microsphere coated glass slides for 0.5, 1.0, 3.0, and 3.5 bilayers of 
heparin and poly-L-lysine. SEM confirmed that the peptoid microsphere morphology was 
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maintained and the LbL films were successfully deposited on the microsphere surface. Figure 5.2 
shows the SEM images for the peptoid microspheres and 0.5 LbL (Figure 5.2A), 1.0 LbL (5.2B), 
3.0 LbL (5.2C), and 3.5 LbL (5.2D). The LbL films are visible on top of the peptoid 
microspheres and the overall coating coverage is maintained.  The topography of the 
microsphere coatings is maintained after HEP/PLL depositions are applied to the top of the 
microspheres. These topographical features are from the three-dimensional spherical morphology 
that the peptoid microspheres create on the surface of the substrates. Overall, the contact angle 
between microspheres is important in creating the topography needed for aECM development.  
 
Figure 5.1 SEM image for peptoid microsphere coatings on a DSS treated 




 Although SEM is useful in generating high-resolution images of object morphology and 
spatial arrangements, it is limited to two-dimensional characterization. The Keyence 3D Laser 
Scanning Optical Microscope (3D LSM) allows for three-dimensional scans of a sample to better 
characterization the surface topography and coating uniformity [18]. The 3D LSM utilizes both 
optical and laser settings to analyze the surface and depth of a material. The peptoid microsphere 
and HEP/PLL films were imaged with the 3D LSM to provide a surface analysis and 3D height 
map of our samples (Figure 5.3). For all of the peptoid microsphere and LbL coatings, the 3D 
LSM images confirmed the presence of both microspheres and HEP/PLL films. The peptoid 
microsphere and 0.5 LbL (HEP)0.5 (Figure 5.3A) and 3.0 LbL (HEP/PLL)3.0 coatings had the best 
surface coverage and were the most uniform. The heat maps for all peptoid microsphere and LbL 
coatings displayed an increase in height as compared to the peptoid microspheres alone. Due to 
Figure 5.2 SEM images for peptoid microsphere coatings with (A) 0.5 layer (Heparin only), 




the low sensitivity of the instrument, the height measurement was inconsistent across 
experimental replicates. There was an increase in the height with added layers, but the starting 
height measurement varied across samples causing the height values given by the 3D scan to be 
inaccurate. Overall, the HEP/PLL films were successfully covered the peptoid microspheres 
without eliminating the desired spherical topography that is created by the microsphere coating. 
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Figure 5.3 3D Laser Scanning Microscope images for (A) 0.5 layer (Heparin only), (B) 1.0 
bilayers (Hep/PLL)1.0, (C) 3.0 bilayers (Hep/PLL)3.0, and (D) 3.5 bilayers (Hep/PLL)3.5.  
 
 82 
5.3.2 Chemical Composition Analysis  
Fourier transform infrared (FTIR) spectroscopy reveals information on the molecular 
nature of chemical compounds and is useful for the characterization of various biopolymers. 
FTIR was used to analyze the presence of specific functional groups on our peptoid microsphere 
and HEP/PLL coatings (Figure 5.4). The peptoid sequence is composed of a repetitive peptide-
like backbone that includes multiple carboxyl and amine groups. The prominent functional 
groups for the peptoid side chains include hydroxyl (-OH) groups on the hydroxybenzylamine 
side chains and a primary amine groups (-NH3+) on the lysine-like side chains. The carboxyl 
group from the peptoid backbone had an intense adsorption peak at 1650 cm-1 (Figure 5.4A). The 
1650 cm-1 peak was present for all of the peptoid microsphere and HEP/PLL coatings, but as 
more bilayers were added the intensity of the peak decreased (Figure 5.4B-D). The number of 
bilayers for this study was increased to 6.0 bilayers of HEP/PLL to increase the coating 
thickness. For 6.0 bilayers, the intensity of the 1650 cm-1 peak drastically decreased by over 
50%. The chemical structure of poly-L-lysine has an abundance of positively charged primary 
amines. The broad peak at 3,000-3,500 cm-1 for the 6.0 bilayer sample (Figure 5.4D) indicates 
the presence of amine bonds (N-H) found in the poly-L-lysine polymer [19]. The FTIR peaks at 
1650-1 and the band at 3,000-3,500-1 confirm the presence of the HEP/PLL films on top of our 






5.3.3 Cytotoxicity/Viability Assay  
Cell viability is determined by the number of live cells on the surface and the overall cell 
morphology. Cells that are alive and spread out on the surface are considered to have high cell 
viability. Healthy astrocyte cells will begin developing cellular networks with neighboring cells 
Figure 5.4 FTIR results for glass slides coated with (A) peptoid microspheres, (B) 0.5 layer 
(Heparin only), (C) 1.0 bilayers (Hep/PLL)1 , (D) 6.0 bilayers (Hep/PLL)6. The inset focused on 
the main peaks at 1650 cm-1 are representative of the carbonyl (C=O) bond that is common in the 
peptoid and heparin structures.  
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[22]. Primary cortical rat astrocytes (passage 6-8) that were isolated from 1-day old neonatal rat 
pups were used to assess the toxicity of our peptoid and LbL surfaces. The cells were grown on 
laminin coated cell culture flasks to confluency and plated on the substrates at 100,000 cells/cm2. 
The samples consisted of uncoated ultraclean glass and ultraclean glass coated with fibronectin 
(positive control), peptoid monomer, peptoid microspheres, peptoid microspheres and 0.5 
bilayers (heparin only), peptoid microspheres and 1.0 bilayers (HEP/PLL)1.0, peptoid 
microspheres and 3.0 bilayers (HEP/PLL)3.0, peptoid microspheres and 3.5 bilayers 
(HEP/PLL)3.5, 0.5 LbL (HEP), and 1.0 LbL (HEP/PLL)1.0. The cells were grown for 3 days prior 
to staining with a Live/Dead® Viability/Cytotoxicity Kit that utilizes green-fluorescent calcein-
AM to indicate intercellular esterase activity and red-fluorescent ethidium homodimer-1 to 
indicate the loss of plasma membrane integrity in dead cells. The ethidium homodimer-1 is a 
nucleic acid stain that enters dead cells through the disintegrated membrane, while the calcein-
AM stains all metabolically active cells [170, 171].   
The cytotoxicity of the fabricated surfaces was analyzed using the live/dead stains and 
imaging with a fluorescent microscope at 10x magnification. The uncoated glass and glass 
coated with fibronectin (+ control), 1.0 LbL (HEP/PLL)1.0, and 3.0 LbL (HEP/PLL)3.0 (Figure 
5.5) were tested in comparison to the peptoid-based surfaces (Figure 5.6). Overall, the only 
surfaces to have a cell survival rate of less than 97% were the uncoated glass slide (33%) (Figure 
5A), peptoid monomer coating (0%) (Figure 6A), and peptoid microsphere coating (0%) (Figure 
6B). The cells did not fully adhere to the plain glass surface and had the poorest cell viability as 
compared to the fibronectin (Figure 5B) and HEP/PLL coated glass (Figure 5C-D). Fibronectin 
was used as the positive control since it is well studied for promoting cellular adhesion and 
proliferation. With the rat astrocytes, the fibronectin surface promoted the best cell adhesion, 
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proliferation, and viability. The glass and LbL surfaces had good cell adhesion, but less cells 
were observed on the surface and they did not branch out compared to those on the fibronectin 
sample. The peptoid monomer (Figure 6A) and microsphere (Figure 6B) coatings facilitated cell 
adhesion, but all the cells were dead after XX time. Just a single layer of heparin added to the 
peptoid microsphere coating (Figure 6C) resulted in increased cell viability with similar cell 
morphology to the fibronectin surface. Similar results were observed for the other peptoid 
microsphere and LbL coatings (Figure 6D-F). There was no difference in cytotoxicity and cell 
viability between the peptoid microsphere and LbL coatings ending in heparin or poly-L-lysine, 










Figure 5.5 Fluorescent microscopy images of rat astrocytes stained with a live/dead assay on 










Figure 5.6 Fluorescent microscopy images of rat astrocytes stained with a live/dead assay on 
(A) peptoid monomer, (B) peptoid microspheres, (C) peptoid microspheres + 0.5 LbL 
(HEP)0.5, (D) peptoid microspheres + 1.0 LbL (HEP/PLL)1.0, (E) peptoid microspheres + 3.0 
LbL (HEP/PLL)3.0, and (F) peptoid microspheres + 3.5 LbL (HEP/PLL)3.5. 
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5.4 Conclusion and Future Studies 
Novel peptoid microsphere and LbL coatings were successfully fabricated for cell 
culturing applications. Peptoid microspheres are suitable anchors for HEP/PLL multilayer 
development to build biomaterials that combine the spherical topography of the peptoid and the 
biocomposition of the LbL polymers. Results revealed that the LbL films up to 3 bilayers are 
able to cover the peptoid microspheres without eliminating the spherical morphology of the 
microspheres. This is important because the end-goal of this material as an aECM substrate is to 
utilize the topography of the surface features to promote stem cell differentiation into specific 
adult cell types. For this, we proved that the novel peptoid and LbL substrates promote cell 
adhesion and are not cytotoxic to the astrocytes. Future plans include gaining a better 
understanding on the surface roughness, mechanical properties, and ability of the surfaces to 
promote stem cell proliferation and differentiation.  
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6. Peptoid Interfaces for Stem Cell Culturing  
6.1 Introduction  
The extracellular matrix (ECM) is a network composed of proteins and macromolecules that 
physically supports the surrounding cells [1]. The ECM plays a major role in dictating stem cell 
fate, primarily due to biochemical, mechanical, and topographical cues [174, 175]. Numerous 
studies have demonstrated that cells are directly affected by specific chemical and mechanical 
properties of naturally occurring ECM components [4]. These cues induce cellular 
communication cascades that influence cell proliferation, differentiation, and apoptosis [5].  
Engineering an artificial extracellular matrix that directly mimics the natural ECM is an 
extremely difficult but critical task for advancing the tissue engineering field. The aECM must 
possess excellent structural integrity and tunability, while also maintaining the bioactivity and 
biocompatibility of naturally occurring ECM components to help improve cellular 
microenvironments [6]. To date, many of the aECMs used for cell culturing have been limited to 
two-dimensional substrates. Since the natural ECM is three-dimensional, these 2-D substrates are 
not able to directly mimic the ECM network. Recently, it was determined that changes in the 
ECM are detected by cell receptors that can dictate cellular gene expression [7]. These changes 
can influence cell survival, shape, mitigation, proliferation, and differentiation [8]. The 
topography and spatial arrangement of features on artificial ECM surfaces have shown to guide 
stem cell attachment and differentiation into specific adult cell types [9]. In designing a 
nanocomposite scaffold that mimics the natural ECM it’s important to combine specific features 
from various materials. The scaffold must have compatible biochemical cues that promote 
cellular adhesion, while also possessing topographical features that promote cellular proliferation 
and differentiation into adult cell types. 
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The main goal of this study was to create a three-dimensional, highly customizable substrate 
that mimics the natural features of the extracellular matrix to promote and guide stem cell 
proliferation and differentiation. The work here shows the development and characterization of 
peptoid microsphere and LbL coatings and their ability to enhance cell adhesion, proliferation, 
and differentiation.  
6.2 Peptoid Substrates and Rat Neural Stem Cell Differentiation 
The objective for this study was to determine the efficacy of the P3 peptoid microspheres as 
an ECM substrate by elucidating the mechanisms that topography plays on stem cell. We 
hypothesize that the topography of our peptoid microsphere surface will directly influence the 
differentiation pathway of neural stem cells into adult neurons or astrocyte cell types.  
In collaboration with the Borrelli Lab at University of Arkansas Medical Sciences, the 
ability of our peptoid microsphere coatings to promote neural stem cell proliferation and 
differentiation was investigated by culturing rat neural stem cells (rNSCs) on our surfaces for 18 
days. Peptoid microsphere coatings were prepared by dissolving the peptoids in 4:1 
ethanol/water (v/v) solution at a concentration of 3 mg/mL. The peptoid solutions were applied 
to glass substrates using a pipette and allowed to dry at room temperature and 60% relative 
humidity for 1 hour. All materials were sterilized with 70% ethanol/water solution or autoclaved 
prior to making the peptoid microsphere coatings Since the peptoid is dissolved in ethanol/water, 
the peptoid coatings were sterilized using UV treatment for 10 minutes prior to culturing cells. 
Three different peptoid microsphere concentrations (1x, 2x, and 3x), or microsphere densities, 
were studied by altering the volume of microsphere solution applied to the glass to form the 
coatings (Figure 6.1).  
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The rNSCs were cultured to confluency prior to plating on the peptoid microsphere 
surfaces for differentiation. After 18 days of differentiation, the cells were fixed with 
paraformaldehyde and stained with β-tubulin for neurons and glial fibrillary acidic protein 
(GFAP) for glial cells. The slides were analyzed with a fluorescent microscope and the results 
displayed excellent cell viability and differentiation to primarily adult neurons (70-80%) versus 
glial cells (20-30%) (Figure 6.2). We believe that the topography of our peptoid microspheres 
plays a role in dictating stem cell differentiation fate.  
 
  
Figure 6.1 3D Laser Scanning Microscopy images of the peptoid microspheres coated at 1X, 
2X, and 3X concentrations for experiments with rat neural stem cell differentiation.  
 
 
Figure 6.2 Day 18 of rat neural stem cell differentiation on peptoid microsphere coatings 
shown by (A) phase contrast microscopy, (B) beta-tubulin stain, and (C) GFAP stain 
fluorescent microscopy (Borrelli Lab). 
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To determine whether microsphere morphology played a role in rNSC differentiation, we 
comparatively cultured the cells on the peptoid monomer coating for 18 days. The peptoid 
monomer is the same P3 12mer sequence, but without forming microspheres. The monomer was 
coated on glass slides by dissolving the peptoid in 100% methanol at a concentration of 5 
mg/mL. The peptoid monomer solution was pipetted onto the glass slides and allowed to dry for 
1 hour at room temperature. The presence of the peptoid monomer on the slides was confirmed 
by using x-ray photoelectron spectroscopy (XPS) indicated by pi-pi bonds present on the surface 
of the coating (Figure 6.3). These pi-pi bond represent the aromatic groups of the methoxy-
benzylamine and (S)-methylbenzylamine side chains present in the peptoid sequence. The rNSCs 
were grown to confluency and plated on the peptoid monomer surface and a laminin control 
surface for differentiation. At days 3, 11, 13, and 18 the surfaces were imaged using a confocal 
light microscope (Figure 6.4). The stem cells adhered to the peptoid monomer died by day 11 
and no proliferation or differentiation was visually seen (Figure 6.4B). The cells on the laminin 
surface showed excellent cell viability and proliferated extensively over the 18 days (Figure 
6.4A). From this study we concluded that the spherical morphology and surface topography of 




6.3 Peptoid Microsphere and PEM Coatings  
The objective of this study was to combine the topography of the peptoid microsphere 
coatings with naturally occurring polymeric depositions in the form of PEMs. It was expected 
Figure 6.3 XPS analysis of peptoid monomer coatings on ultraclean glass slides.  
 
 
 Figure 6.4 Phase contrast microscopy of rat neural stem cell differentiation on (A) Laminin 
control and (B) peptoid monomer coated glass slide after 3, 11, 13, and 18 days (Borrelli Lab).  
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that the PEMs would utilize the positive surface charge of the peptoid microspheres to create thin 
films across the top of the surface. Our work described here focused on the development of 
peptoid microsphere coatings that incorporate heparin and collagen or heparin and poly-L-lysine 
multilayered films. We determined that by adding 3-6 bilayers of heparin/collagen or 
heparin/poly(L-lysine) the films are thin enough to completely cover the microspheres, but the 
spherical morphology was still present. The layer-by-layer application method was tested and we 
determined that drop-coating (previous chapter), dip-coating, and spin-coating all created 
uniform PEM films on the peptoid microsphere surface. Schwann cells and bone-marrow derived 
human mesenchymal stem cells (hMSCs) were cultured on the newly developed substrates to test 
their efficacy in promoting cell adhesion and proliferation.   
6.3.1 Dip-Coating Fabrication of PEM Films 
Utilizing the positive surface charge of the peptoid microspheres and a previously 
established layer-by-layer method [10], we are able to fabricate heparin/poly(L-lysine) 
(HEP/PLL) and heparin/collagen (HEP/COL) thin films across the top of our microspheres. 
Peptoid microsphere coatings were made following the previously described method at a 
concentration of 3 mg/mL on ultraclean glass slides. All polymers (heparin, poly(L-lysine), and 
collagen) were held at a constant concentration of 1 mg/mL in PBS, except the type-1-collagen 
must be dissolved in an acetate buffer. The peptoid microsphere coated glass slide was dipped in 
the polymer solution for 5 minutes followed by a wash step in PBS for 3 minutes. This was 
repeated for each individual polymer layer until samples with a single layer of heparin (sample 
0.5), a single bilayer (sample 1.0), and 6 bilayers (sample 6.0) were reached. To determine the 
efficiency of our coating method we visually analyzed the sample using SEM. The results 
showed that the peptoid microspheres formed uniform coatings alone (Figure 6.5A) and a single 
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layer of heparin (Figure 6.5B) added successfully to the peptoid microspheres. However, the 6 
bilayers of heparin/poly(L-lysine) formed feather-like appendages that extended across the 
surface (Figure 6.5C). The peptoid microspheres were present underneath 6 bilayers confirmed 
by the cross-sectional SEM (Figure 6.5D), but little microsphere topography was preserved due 
to the increased PEM thickness. The characterization process was repeated for the peptoid 
microsphere and HEP/COL PEM coatings as well.  
 
6.3.2 Peptoid Microspheres + HEP/COL Coatings 
PEM films of heparin/collagen were prepared on glass substrates (positive control) and 
across the peptoid microsphere coatings by following the LbL method previously mentioned. 
Both samples consisted of 6 bilayers of heparin and collagen. Schwann cells and hMSCs were 
Figure 6.5 SEM images of (A) peptoid microspheres, (B) peptoid microspheres + 0.5 
bilayers (Hep)0.5, (C) peptoid microspheres + 6.0 bilayers (Hep/PLL)6.0, and (D) cross section 
of peptoid microspheres + 6.0 bilayers (Hep/PLL)6.0. 
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cultured on the LbL (HEP/COL)6.0 and peptoid microspheres + LbL (HEP/COL)6.0, surfaces for 3 
days to determine the efficacy of the newly developed substrates for cell culturing. After day 3, 
the cells were fixed using paraformaldehyde and stained with Hoescht for the cell nuclei (blue) 
and Actin Red (red) for the cytoskeleton. Using ImageJ, the representative fluorescent 
microscope images of the Schwann cells and hMSCs were overlaid to display both cell nuclei 
and cytoskeleton directly. These images showed that the Schwann cells adhered to both surfaces 
and expanded (Figure 6.6). Both surfaces promoted excellent hMSC adhesion and expansion, 
while also enhanced cell proliferation (Figure 6.7). The hMSCs also displayed actin fiber 
filaments for both surfaces indicating healthy cellular behaviour. Actin filaments are a part of the 
MSCs cytoskeleton and has a major role in the mechanical properties of the cells by anchoring to 
the nucleus and holding it in place [11]. These studies provide necessary data to suggest further 
investigating the potential of peptoid microspheres and PEM films as aECM substrates. 
 
 
Figure 6.6 Study of morphology and extension of Schwann cells on (A) (HEP/COL)6 and (B) 
peptoid microspheres + (HEP/COL)6 surfaces. Representative fluorescence microscopic 
overlay images of Schwann Cells nuclei and actin labeled with Hoescht (blue) and Actin Red 




6.3.3 Peptoid Microspheres + HEP/PLL Coatings 
PEM films of heparin/poly-L-lysine were prepared on glass substrates (positive control) 
and across the peptoid microsphere coatings by following the LbL method previously mentioned 
(Figure 6.5). Both samples consisted of 6 bilayers of heparin and PLL. hMSCs were cultured on 
the 6.0 LbL (HEP/PLL)6.0 and peptoid microspheres + 6.0 LbL (HEP/PLL)6.0, surfaces for 3 days 
to determine the efficacy of the newly developed substrates for cell culturing. After day 3, the 
cells were fixed using paraformaldehyde and stained with Hoescht for the cell nuclei (blue) and 
Actin Red (red) for the cytoskeleton. Optical microscopy showed the cells adhered to the glass 
control, peptoid microspheres, peptoid microspheres and 0.5 LbL (HEP)0.5, and peptoid 
microspheres and 6.0 LbL (HEP/PLL)6.0 coatings after 1 day (Figure 6.8). The cells on the 
peptoid microsphere samples were difficult to see using the inverted microscope due to the 
opaqueness of the coatings. The darker spots on the images represent the hMSCs (Figure 6.8B-
D). Using ImageJ, the representative fluorescent microscope images of the hMSCs were overlaid 
to display both cell nuclei and cytoskeleton directly (Figure 6.9) The hMSCs grew extensively 
Figure 6.7 Study of morphology and extension of human mesenchymal stem cells (hMSCs) 
on (A) (HEP/COL)6 and (B) peptoid microspheres + (HEP/COL)6 surfaces. Representative 
fluorescence microscopic overlay images of MSC nuclei labeled with Hoescht (blue) and 
Actin Red (red), respectively, after 3 days of culture.  
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on the glass control substrate indicated by the increased number and morphology of the cells on 
the surface (Figure 6.9A). The peptoid microsphere coatings had issues with background 
fluorescence, but the stained cells adhered to all of the coatings. The morphology of the cells on 
the peptoid and LbL coatings differed from the glass control in that the cells never spread out 




Figure 6.8 Light optical microscope images of human mesenchymal stem cells after 1 day on 
(A) Glass substrate (B) peptoid microspheres (C) peptoid microspheres and 0.5 LbL (HEP)0.5, 




6.4 Peptoid Monomer and Microspheres in Solution 
The goal of this study was to determine the effect that peptoid concentration had on hMSC 
growth. To do so, we investigated the cell growth by adding differing concentrations of peptoid 
monomer and microspheres directly to the cell media instead of forming peptoid coatings (Figure 
6.10). In forming the peptoid monomer, the P3 peptoid was dissolved in water and diluted to 1 
mg/mL in PBS and 100 µL or 200 µL of the peptoid monomer solution was added to a well 
plate. The hMSCs in cell media were added to form a final volume of 1 mL per well. The final 
peptoid monomer concentrations were 0.1 mg/mL and 0.2 mg/mL in each of the two wells. 
Results showed that peptoid monomer concentration plays a role in hMSC viability as the higher 
Figure 6.9 Study of morphology and extension of human mesenchymal stem cells (hMSCs) 
on (A) Glass substrate (B) peptoid microspheres (C) peptoid microspheres and 0.5 LbL 
(HEP)0.5, and (D) peptoid microspheres and 6.0 LbL (HEP/PLL)6.0. Representative 
fluorescence microscopic overlay images of MSC nuclei labeled with Hoescht (blue) and 
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concentrated peptoid monomer solution had no cell adherence and growth. The lower 
concentration, 0.1 mg/mL (Figure 6.10C), resulted in improved cell viability as compared to the 
TCPS control (Figure 6.10A). The peptoid monomer at lower concentrations was proven to be 
non-toxic to the MSCs.   
The P3 microspheres were formed by dissolving the peptoid in 4:1 ethanol and water at a 
concentration of 1 mg/mL. The peptoid microsphere solution was then diluted in dPBS to a 
concentration of 0.1 mg/mL and the solution was centrifuged for 10 minutes. The top layer was 
pipetted off to remove the ethanol. This was repeated 4 times and set in the hood to allow 
residual ethanol to evaporate. The peptoid microsphere solution (100 µL or 200 µL) was added 
to the well plate with hMSCs in media to a final volume of 1 mL per well, for a final peptoid 
microsphere concentrations of ~0.01 mg/mL and ~0.02 mg/mL. Results showed that both 
peptoid microsphere concentrations were below the threshold that prevents MSC from adhering 
and extending out (Figure 6.10D-E). Both peptoid microsphere concentrations in solution had 
better cell viability than the TCPS control sample. The hMSCs grown on the higher peptoid 
microsphere concentration grew in more linear patterns, indicating that the microspheres in the 
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media might play a role in cell arrangement (Figure 6.10E). 
 
6.5 Spin-Coating Peptoid Microspheres and LbL Films  
Spin-coating is a widely used deposition method that can coat substrates uniformly with 
relative ease. It involves casting a material onto a spinning substrate, typically with a pipette 
[12]. The centrifugal force pushes the liquid outwards coating the entire substrate and allows for 
the fast evaporation of solvent. Since spin-coated is an efficient method of coating substrates, we 
decided to study its efficacy as a fabrication technique for our peptoid microspheres and LbL 
coatings. First, we wanted to see if spin-coating could drastically reduce the drying time and 
conditions (e.g. humidity, tween, airflow) that drop-coating peptoid microspheres required. For 
each sample, 30 µL of peptoid microsphere solution was pipetted onto a 25mm x 25mm 
Figure 6.10 Study of morphology and extension of human mesenchymal stem cells (hMSCs) 
on (A) tissue culturing polystyrene (well-plate), (B) 0.2 mg/mL peptoid monomer, and (C) 0.1 
mg/mL peptoid monomer (D) 0.01 mg/mL peptoid microspheres, and (E) 0.02 mg/mL 
peptoid microspheres in solution. Representative fluorescence microscopic images of MSC 




ultraclean glass slide and the solution was spun for 30 seconds at the desired speed. We 
investigated two spin-speeds of 500 RPM and 1,000 RPM. The coatings were characterized 
using 3D Laser Scanning Optical Microscopy (Figure 6.11). Both spin speeds formed peptoid 
microspheres on the surface, but the 1,000 RPM sample pushed the microspheres from the center 
due to the increased centrifugal force. This caused a ring-like effect where more microspheres 
were present at the edges of the glass slide (Figure 6.11A).  The 500 RPM sample had more 
uniform coverage on the glass slide than the higher speed. Both samples had more efficient 
drying of the ethanol/water solvent mixture than the traditional drop-casting method. By spin-
coating the peptoid microspheres onto the glass slides we were able to cut down the drying time 






Figure 6.11 3D Laser Scanning Optical Microscope analysis of peptoid microspheres spin-
coated onto an ultraclean glass slide at (A) 1,000 RPM (optical + laser) and (B) 500 RPM 
(laser only).  
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The ability to spin-coat LbL depositions on the microsphere substrates would potentially 
reduce synthesis time and create more uniform coatings. In doing so, a spin-coating technique 
that involved spinning each polymer at 5,000 RPM for 1 minute followed by a water wash at the 
same spin speed for 1 minute was used to form HEP/PLL bilayers. This process is repeated for 
each subsequent layer until the desired number of bilayers are formed. Once the bilayers were 
formed, the samples were fully dried with nitrogen gas and stored in a sterile environment for 
testing. Then, a single layer of heparin (HEP)0.5, 1 bilayer (HEP/PLL)1.0, and 3 bilayers 
(HEP/PLL)3.0 were spin coated onto the peptoid microsphere substrates. 3D LSM images of the 
spin-coated LbL and peptoid microsphere coatings confirmed the presence of the films on the 
microspheres (Figure 6.12A-C). It is important that the spin-coating did not disrupt the peptoid 
microsphere morphology, since it will be utilized to potential dictate stem cell fate. All three 
coating thicknesses successfully preserved the microsphere morphology, while adding thin 
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7. Conclusion and Future Directions 
The increased presence of biomimetic materials for biomedical applications has led to the 
development of more complex technologies. Specifically, there is a need for a material that is 
cost-effective, bioavailable, and tunable for various applications. This dissertation demonstrates 
the potential of peptoid microspheres as biomaterials for biosensing and cell manufacturing. In 
addition, the ability of the microspheres to serve as anchors for PEM development increases their 
potential in tissue engineering. The customizability and robustness of the peptoid microsphere 
substrate is invaluable as a biomimetic material. The use of peptoids in the form of uniform 
peptoid microsphere coatings offers a promising technology in biosensor and aECM substrate 
development. This dissertation studied (1) the physical and thermal properties of the peptoid 
microspheres along with their robustness in biological environments (Chapter 3), (2) the ability 
of peptoid microsphere coatings to enhance ELISA microarray technology (Chapter 4), (3) the 
tunability of the peptoid microsphere coatings by adding PEM films (chapter 5), and (4) the 
efficacy of peptoid microsphere and LbL coatings in cell culturing applications (Chapter 6). Our 
results found that varying peptoid chain length allows for the rational tuning of microsphere size. 
It has been demonstrated that the peptoid microsphere coatings are extremely robust for 
applications at physiological conditions. Results showed that the use of peptoid microsphere 
coatings as a novel surface for ELISA microarrays enhances the limits of detection and signal-to-
noise ratios. It has also been proven that LbL technologies can be added to the surface of our 
peptoid microsphere coatings to create a more biocompatible and novel interface for cell 
culturing. These new materials have been proven to be non-toxic and effective in cell adhesion, 
proliferation, and viability.  
Future studies for the physical properties of the peptoid microspheres should focus on 
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providing valuable insight into the mechanism of formation of the microsphere tertiary structure. 
By working with the Center for Integrative Nanotechnologies at Los Alamos National Lab the 
packing nature and self-assembly mechanism of the peptoid molecules can be further 
investigated. This study should conclude whether the peptoid microspheres are packed or hollow, 
the effect of peptoid chain length on packing density, and exactly how the peptoids are arranged 
in forming the microspheres. The charge distribution of the spheres could yield insight into the 
conformation and arrangement of peptoids in the microspheres. To gather this data, the use of 
grazing incidence small-angle x-ray scattering (GISAXS) from a synchrotron would provide the 
needed beam flux and q-resolution needed for the size of our peptoid molecules. From this data, 
it would be possible to create molecular dynamic simulations to model the formation of 
microspheres. These simulations could be carried over to provide an infrastructure to better 
model drug loading and delivery along with cell signaling interactions. For the LbL work, the 
uniformity of the depositions can be optimized, and the coatings characterized further using zeta-
potential, XPS, and ellipsometry to provide feedback on the surface charge, chemical 
composition, and film thickness, respectively. It would be valuable to further determine the role 
that peptoid concentration and morphology plays on stem cells, and whether the peptoid 
microspheres influence the fate of stem cell differentiation.  
 
  
 
